"","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-5675221","R-HSA-5675221","Negative regulation of MAPK pathway","10/45","34/2914",2.67895867628375e-11,1.22160515638539e-08,6.57049864814857e-09,"MAPK3/PPP2CA/DUSP9/MAPK1/PPP2CB/DUSP2/DUSP6/PPP2R1B/DUSP8/DUSP10",10
"R-HSA-450282","R-HSA-450282","MAPK targets/ Nuclear events mediated by MAP kinases","9/45","30/2914",2.42829104245554e-10,4.50190593406773e-08,2.42138523231251e-08,"MAPK3/PPP2CA/MAPK1/RPS6KA2/MAPK9/RPS6KA3/PPP2CB/DUSP6/PPP2R1B",9
"R-HSA-198753","R-HSA-198753","ERK/MAPK targets","8/45","21/2914",2.9617802197814e-10,4.50190593406773e-08,2.42138523231251e-08,"MAPK3/PPP2CA/MAPK1/RPS6KA2/RPS6KA3/PPP2CB/DUSP6/PPP2R1B",8
"R-HSA-112409","R-HSA-112409","RAF-independent MAPK1/3 activation","8/45","23/2914",6.97550445361106e-10,7.95207507711661e-08,4.27708562550362e-08,"MAPK3/DUSP9/MAPK1/DUSP2/DUSP6/PEA15/DUSP8/DUSP10",8
"R-HSA-198725","R-HSA-198725","Nuclear Events (kinase and transcription factor activation)","8/45","24/2914",1.03445465200879e-09,9.43422642632014e-08,5.07427229301152e-08,"MAPK3/PPP2CA/MAPK1/RPS6KA2/RPS6KA3/PPP2CB/DUSP6/PPP2R1B",8
"R-HSA-202670","R-HSA-202670","ERKs are inactivated","6/45","12/2914",8.29977503714385e-09,6.30782902822933e-07,3.39271505904301e-07,"MAPK3/PPP2CA/MAPK1/PPP2CB/DUSP6/PPP2R1B",6
"R-HSA-69278","R-HSA-69278","Cell Cycle, Mitotic","15/45","191/2914",6.19683818453868e-08,4.03679744592806e-06,2.17122300300378e-06,"E2F1/MAPK3/PPP2CA/MAPK1/CSNK2A1/MAX/EP300/TFDP1/TP53/GSK3B/PPP2CB/CSNK2A2/PPP1CB/SET/PPP2R1B",15
"R-HSA-5673001","R-HSA-5673001","RAF/MAP kinase cascade","14/45","171/2914",1.14502531088483e-07,6.26946994536201e-06,3.37208332702989e-06,"MAPK3/PPP2CA/DUSP9/MAPK1/WDR83/PPP2CB/DUSP2/FGF19/DUSP6/PPP2R1B/PEA15/CAMK2A/DUSP8/DUSP10",14
"R-HSA-9006925","R-HSA-9006925","Intracellular signaling by second messengers","15/45","201/2914",1.23739538395303e-07,6.26946994536201e-06,3.37208332702989e-06,"MAPK3/PPP2CA/LCK/MAPK1/CSNK2A1/NR4A1/TP53/GSK3B/PPP2CB/CSNK2A2/PRKCD/FGF19/GSK3A/PPP2R1B/CAMK2A",15
"R-HSA-5663202","R-HSA-5663202","Diseases of signal transduction","17/45","268/2914",1.51822724787415e-07,6.27175814098705e-06,3.37331405090024e-06,"NOTCH1/SMAD3/MAPK3/PPP2CA/SMAD4/LCK/MAPK1/EP300/STAT3/NR4A1/GSK3B/PPP2CB/AMER1/FGF19/GSK3A/PPP2R1B/CAMK2A",17
"R-HSA-113501","R-HSA-113501","Inhibition of replication initiation of damaged DNA by RB1/E2F1","5/45","10/2914",1.66566159039239e-07,6.27175814098705e-06,3.37331405090024e-06,"E2F1/PPP2CA/TFDP1/PPP2CB/PPP2R1B",5
"R-HSA-5684996","R-HSA-5684996","MAPK1/MAPK3 signaling","14/45","177/2914",1.77600799858664e-07,6.27175814098705e-06,3.37331405090024e-06,"MAPK3/PPP2CA/DUSP9/MAPK1/WDR83/PPP2CB/DUSP2/FGF19/DUSP6/PPP2R1B/PEA15/CAMK2A/DUSP8/DUSP10",14
"R-HSA-450294","R-HSA-450294","MAP kinase activation","9/45","60/2914",1.7880012244042e-07,6.27175814098705e-06,3.37331405090024e-06,"MAPK3/PPP2CA/MAPK1/RPS6KA2/MAPK9/RPS6KA3/PPP2CB/DUSP6/PPP2R1B",9
"R-HSA-113510","R-HSA-113510","E2F mediated regulation of DNA replication","5/45","11/2914",3.018728243585e-07,9.67644415351535e-06,5.20455098746324e-06,"E2F1/PPP2CA/TFDP1/PPP2CB/PPP2R1B",5
"R-HSA-448424","R-HSA-448424","Interleukin-17 signaling","9/45","64/2914",3.18340155474769e-07,9.67644415351535e-06,5.20455098746324e-06,"MAPK3/PPP2CA/MAPK1/RPS6KA2/MAPK9/RPS6KA3/PPP2CB/DUSP6/PPP2R1B",9
"R-HSA-2262752","R-HSA-2262752","Cellular responses to stress","14/45","187/2914",3.55256123978186e-07,9.67644415351535e-06,5.20455098746324e-06,"E2F1/MAPK3/MAPK1/RPS6KA2/EP300/HIF1A/STAT3/SP1/TFDP1/TP53/MAPK9/RPS6KA3/GSK3B/CAMK2A",14
"R-HSA-9607240","R-HSA-9607240","FLT3 Signaling","14/45","188/2914",3.79822454959038e-07,9.67644415351535e-06,5.20455098746324e-06,"MAPK3/PPP2CA/DUSP9/MAPK1/WDR83/PPP2CB/DUSP2/FGF19/DUSP6/PPP2R1B/PEA15/CAMK2A/DUSP8/DUSP10",14
"R-HSA-212436","R-HSA-212436","Generic Transcription Pathway","22/45","481/2914",3.81964900796658e-07,9.67644415351535e-06,5.20455098746324e-06,"NOTCH1/E2F1/SMAD3/MAPK3/PPP2CA/SMAD4/MAPK1/CSNK2A1/GATA3/ZNF521/MAX/EP300/SP1/NR4A1/TFDP1/SOCS3/TP53/GSK3B/PPP2CB/CSNK2A2/PPP2R1B/CAMK2A",22
"R-HSA-8953897","R-HSA-8953897","Cellular responses to external stimuli","14/45","189/2914",4.05913592690425e-07,9.74192622457021e-06,5.23977103029746e-06,"E2F1/MAPK3/MAPK1/RPS6KA2/EP300/HIF1A/STAT3/SP1/TFDP1/TP53/MAPK9/RPS6KA3/GSK3B/CAMK2A",14
"R-HSA-187037","R-HSA-187037","Signaling by NTRK1 (TRKA)","9/45","70/2914",7.02269838120426e-07,1.33831909758393e-05,7.19825368737432e-06,"MAPK3/PPP2CA/MAPK1/RPS6KA2/STAT3/RPS6KA3/PPP2CB/DUSP6/PPP2R1B",9
"R-HSA-73857","R-HSA-73857","RNA Polymerase II Transcription","22/45","499/2914",7.42829140024607e-07,1.33831909758393e-05,7.19825368737432e-06,"NOTCH1/E2F1/SMAD3/MAPK3/PPP2CA/SMAD4/MAPK1/CSNK2A1/GATA3/ZNF521/MAX/EP300/SP1/NR4A1/TFDP1/SOCS3/TP53/GSK3B/PPP2CB/CSNK2A2/PPP2R1B/CAMK2A",22
"R-HSA-2559585","R-HSA-2559585","Oncogene Induced Senescence","6/45","23/2914",7.98399817941921e-07,1.33831909758393e-05,7.19825368737432e-06,"E2F1/MAPK3/MAPK1/SP1/TFDP1/TP53",6
"R-HSA-4839735","R-HSA-4839735","AXIN mutants destabilize the destruction complex, activating WNT signaling","5/45","13/2914",8.2177488448136e-07,1.33831909758393e-05,7.19825368737432e-06,"PPP2CA/GSK3B/PPP2CB/AMER1/PPP2R1B",5
"R-HSA-4839744","R-HSA-4839744","truncated APC mutants destabilize the destruction complex","5/45","13/2914",8.2177488448136e-07,1.33831909758393e-05,7.19825368737432e-06,"PPP2CA/GSK3B/PPP2CB/AMER1/PPP2R1B",5
"R-HSA-4839748","R-HSA-4839748","AMER1 mutants destabilize the destruction complex","5/45","13/2914",8.2177488448136e-07,1.33831909758393e-05,7.19825368737432e-06,"PPP2CA/GSK3B/PPP2CB/AMER1/PPP2R1B",5
"R-HSA-5467337","R-HSA-5467337","APC truncation mutants have impaired AXIN binding","5/45","13/2914",8.2177488448136e-07,1.33831909758393e-05,7.19825368737432e-06,"PPP2CA/GSK3B/PPP2CB/AMER1/PPP2R1B",5
"R-HSA-5467340","R-HSA-5467340","AXIN missense mutants destabilize the destruction complex","5/45","13/2914",8.2177488448136e-07,1.33831909758393e-05,7.19825368737432e-06,"PPP2CA/GSK3B/PPP2CB/AMER1/PPP2R1B",5
"R-HSA-5467348","R-HSA-5467348","Truncations of AMER1 destabilize the destruction complex","5/45","13/2914",8.2177488448136e-07,1.33831909758393e-05,7.19825368737432e-06,"PPP2CA/GSK3B/PPP2CB/AMER1/PPP2R1B",5
"R-HSA-5683057","R-HSA-5683057","MAPK family signaling cascades","14/45","202/2914",9.27820370266783e-07,1.41986964631128e-05,7.63687967660499e-06,"MAPK3/PPP2CA/DUSP9/MAPK1/WDR83/PPP2CB/DUSP2/FGF19/DUSP6/PPP2R1B/PEA15/CAMK2A/DUSP8/DUSP10",14
"R-HSA-1257604","R-HSA-1257604","PIP3 activates AKT signaling","13/45","172/2914",9.34124767310052e-07,1.41986964631128e-05,7.63687967660499e-06,"MAPK3/PPP2CA/LCK/MAPK1/CSNK2A1/NR4A1/TP53/GSK3B/PPP2CB/CSNK2A2/FGF19/GSK3A/PPP2R1B",13
"R-HSA-4839743","R-HSA-4839743","phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex","5/45","14/2914",1.26367345879893e-06,1.60065304781198e-05,8.60923730702194e-06,"PPP2CA/GSK3B/PPP2CB/AMER1/PPP2R1B",5
"R-HSA-5339716","R-HSA-5339716","Misspliced GSK3beta mutants stabilize beta-catenin","5/45","14/2914",1.26367345879893e-06,1.60065304781198e-05,8.60923730702194e-06,"PPP2CA/GSK3B/PPP2CB/AMER1/PPP2R1B",5
"R-HSA-5358747","R-HSA-5358747","S33 mutants of beta-catenin aren't phosphorylated","5/45","14/2914",1.26367345879893e-06,1.60065304781198e-05,8.60923730702194e-06,"PPP2CA/GSK3B/PPP2CB/AMER1/PPP2R1B",5
"R-HSA-5358749","R-HSA-5358749","S37 mutants of beta-catenin aren't phosphorylated","5/45","14/2914",1.26367345879893e-06,1.60065304781198e-05,8.60923730702194e-06,"PPP2CA/GSK3B/PPP2CB/AMER1/PPP2R1B",5
"R-HSA-5358751","R-HSA-5358751","S45 mutants of beta-catenin aren't phosphorylated","5/45","14/2914",1.26367345879893e-06,1.60065304781198e-05,8.60923730702194e-06,"PPP2CA/GSK3B/PPP2CB/AMER1/PPP2R1B",5
"R-HSA-5358752","R-HSA-5358752","T41 mutants of beta-catenin aren't phosphorylated","5/45","14/2914",1.26367345879893e-06,1.60065304781198e-05,8.60923730702194e-06,"PPP2CA/GSK3B/PPP2CB/AMER1/PPP2R1B",5
"R-HSA-2559583","R-HSA-2559583","Cellular Senescence","10/45","99/2914",1.54159987395703e-06,1.89991768249839e-05,1.02188554945089e-05,"E2F1/MAPK3/MAPK1/RPS6KA2/STAT3/SP1/TFDP1/TP53/MAPK9/RPS6KA3",10
"R-HSA-168142","R-HSA-168142","Toll Like Receptor 10 (TLR10) Cascade","9/45","78/2914",1.79826825717375e-06,2.05002581317807e-05,1.10262237874074e-05,"MAPK3/PPP2CA/MAPK1/RPS6KA2/MAPK9/RPS6KA3/PPP2CB/DUSP6/PPP2R1B",9
"R-HSA-168176","R-HSA-168176","Toll Like Receptor 5 (TLR5) Cascade","9/45","78/2914",1.79826825717375e-06,2.05002581317807e-05,1.10262237874074e-05,"MAPK3/PPP2CA/MAPK1/RPS6KA2/MAPK9/RPS6KA3/PPP2CB/DUSP6/PPP2R1B",9
"R-HSA-975871","R-HSA-975871","MyD88 cascade initiated on plasma membrane","9/45","78/2914",1.79826825717375e-06,2.05002581317807e-05,1.10262237874074e-05,"MAPK3/PPP2CA/MAPK1/RPS6KA2/MAPK9/RPS6KA3/PPP2CB/DUSP6/PPP2R1B",9
"R-HSA-1640170","R-HSA-1640170","Cell Cycle","15/45","249/2914",2.07688815921098e-06,2.3099048795127e-05,1.24240036224944e-05,"E2F1/MAPK3/PPP2CA/MAPK1/CSNK2A1/MAX/EP300/TFDP1/TP53/GSK3B/PPP2CB/CSNK2A2/PPP1CB/SET/PPP2R1B",15
"R-HSA-196299","R-HSA-196299","Beta-catenin phosphorylation cascade","5/45","16/2914",2.69430693937509e-06,2.92524753417867e-05,1.57336721021152e-05,"PPP2CA/GSK3B/PPP2CB/AMER1/PPP2R1B",5
"R-HSA-975138","R-HSA-975138","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation","9/45","83/2914",3.0620893591456e-06,3.24723894830324e-05,1.74655280460447e-05,"MAPK3/PPP2CA/MAPK1/RPS6KA2/MAPK9/RPS6KA3/PPP2CB/DUSP6/PPP2R1B",9
"R-HSA-168181","R-HSA-168181","Toll Like Receptor 7/8 (TLR7/8) Cascade","9/45","84/2914",3.39074999852174e-06,3.43595999850203e-05,1.84805789393115e-05,"MAPK3/PPP2CA/MAPK1/RPS6KA2/MAPK9/RPS6KA3/PPP2CB/DUSP6/PPP2R1B",9
"R-HSA-975155","R-HSA-975155","MyD88 dependent cascade initiated on endosome","9/45","84/2914",3.39074999852174e-06,3.43595999850203e-05,1.84805789393115e-05,"MAPK3/PPP2CA/MAPK1/RPS6KA2/MAPK9/RPS6KA3/PPP2CB/DUSP6/PPP2R1B",9
"R-HSA-166058","R-HSA-166058","MyD88:MAL(TIRAP) cascade initiated on plasma membrane","9/45","86/2914",4.14024404923323e-06,3.93323184677156e-05,2.11551943743715e-05,"MAPK3/PPP2CA/MAPK1/RPS6KA2/MAPK9/RPS6KA3/PPP2CB/DUSP6/PPP2R1B",9
"R-HSA-168138","R-HSA-168138","Toll Like Receptor 9 (TLR9) Cascade","9/45","86/2914",4.14024404923323e-06,3.93323184677156e-05,2.11551943743715e-05,"MAPK3/PPP2CA/MAPK1/RPS6KA2/MAPK9/RPS6KA3/PPP2CB/DUSP6/PPP2R1B",9
"R-HSA-168188","R-HSA-168188","Toll Like Receptor TLR6:TLR2 Cascade","9/45","86/2914",4.14024404923323e-06,3.93323184677156e-05,2.11551943743715e-05,"MAPK3/PPP2CA/MAPK1/RPS6KA2/MAPK9/RPS6KA3/PPP2CB/DUSP6/PPP2R1B",9
"R-HSA-168164","R-HSA-168164","Toll Like Receptor 3 (TLR3) Cascade","9/45","87/2914",4.56570470191356e-06,4.08227714524036e-05,2.19568461412974e-05,"MAPK3/PPP2CA/MAPK1/RPS6KA2/MAPK9/RPS6KA3/PPP2CB/DUSP6/PPP2R1B",9
"R-HSA-168179","R-HSA-168179","Toll Like Receptor TLR1:TLR2 Cascade","9/45","87/2914",4.56570470191356e-06,4.08227714524036e-05,2.19568461412974e-05,"MAPK3/PPP2CA/MAPK1/RPS6KA2/MAPK9/RPS6KA3/PPP2CB/DUSP6/PPP2R1B",9
"R-HSA-181438","R-HSA-181438","Toll Like Receptor 2 (TLR2) Cascade","9/45","87/2914",4.56570470191356e-06,4.08227714524036e-05,2.19568461412974e-05,"MAPK3/PPP2CA/MAPK1/RPS6KA2/MAPK9/RPS6KA3/PPP2CB/DUSP6/PPP2R1B",9
"R-HSA-166520","R-HSA-166520","Signaling by NTRKs","9/45","89/2914",5.53063788861004e-06,4.84994399462726e-05,2.60858021871688e-05,"MAPK3/PPP2CA/MAPK1/RPS6KA2/STAT3/RPS6KA3/PPP2CB/DUSP6/PPP2R1B",9
"R-HSA-166166","R-HSA-166166","MyD88-independent TLR4 cascade ","9/45","90/2914",6.07557372869205e-06,5.13048448200662e-05,2.75947110874317e-05,"MAPK3/PPP2CA/MAPK1/RPS6KA2/MAPK9/RPS6KA3/PPP2CB/DUSP6/PPP2R1B",9
"R-HSA-937061","R-HSA-937061","TRIF(TICAM1)-mediated TLR4 signaling ","9/45","90/2914",6.07557372869205e-06,5.13048448200662e-05,2.75947110874317e-05,"MAPK3/PPP2CA/MAPK1/RPS6KA2/MAPK9/RPS6KA3/PPP2CB/DUSP6/PPP2R1B",9
"R-HSA-68875","R-HSA-68875","Mitotic Prophase","6/45","33/2914",7.80242862115203e-06,6.46892263862787e-05,3.47936051431277e-05,"MAPK3/PPP2CA/MAPK1/PPP2CB/SET/PPP2R1B",6
"R-HSA-442742","R-HSA-442742","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","5/45","22/2914",1.51589194896311e-05,0.000123436915844139,6.63915082910533e-05,"MAPK3/MAPK1/RPS6KA2/RPS6KA3/CAMK2A",5
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","16/45","332/2914",1.63754658308738e-05,0.00013100372664699,7.04613765206573e-05,"SMAD3/MAPK3/PPP2CA/LCK/MAPK1/GATA3/RPS6KA2/HIF1A/STAT3/SOCS3/TP53/MAPK9/RPS6KA3/PPP2CB/DUSP6/PPP2R1B",16
"R-HSA-1912408","R-HSA-1912408","Pre-NOTCH Transcription and Translation","5/45","23/2914",1.91479527317669e-05,0.000150542524925616,8.09704716243501e-05,"NOTCH1/E2F1/EP300/TFDP1/TP53",5
"R-HSA-166016","R-HSA-166016","Toll Like Receptor 4 (TLR4) Cascade","9/45","110/2914",3.1795507279128e-05,0.000245741547784447,0.000132174008849899,"MAPK3/PPP2CA/MAPK1/RPS6KA2/MAPK9/RPS6KA3/PPP2CB/DUSP6/PPP2R1B",9
"R-HSA-2559580","R-HSA-2559580","Oxidative Stress Induced Senescence","6/45","44/2914",4.37813675069233e-05,0.000332049044998199,0.000178595169631995,"E2F1/MAPK3/MAPK1/TFDP1/TP53/MAPK9",6
"R-HSA-1295596","R-HSA-1295596","Spry regulation of FGF signaling","4/45","14/2914",4.44188415458117e-05,0.000332049044998199,0.000178595169631995,"MAPK3/PPP2CA/MAPK1/PPP2CB",4
"R-HSA-5654733","R-HSA-5654733","Negative regulation of FGFR4 signaling","5/45","28/2914",5.27975248209748e-05,0.00038831727932846,0.000208859478493839,"MAPK3/PPP2CA/MAPK1/PPP2CB/FGF19",5
"R-HSA-453274","R-HSA-453274","Mitotic G2-G2/M phases","7/45","68/2914",6.19061763460304e-05,0.000448082800218887,0.0002410048302193,"E2F1/PPP2CA/EP300/TP53/PPP2CB/PPP1CB/PPP2R1B",7
"R-HSA-1912422","R-HSA-1912422","Pre-NOTCH Expression and Processing","5/45","29/2914",6.30668128286156e-05,0.000449351041403886,0.000241686963635978,"NOTCH1/E2F1/EP300/TFDP1/TP53",5
"R-HSA-4641262","R-HSA-4641262","Disassembly of the destruction complex and recruitment of AXIN to the membrane","5/45","30/2914",7.48140240185001e-05,0.0005248491531144,0.000282294212086,"PPP2CA/GSK3B/PPP2CB/AMER1/PPP2R1B",5
"R-HSA-109606","R-HSA-109606","Intrinsic Pathway for Apoptosis","6/45","49/2914",8.18499814602566e-05,0.000565508962816318,0.000304163407978306,"E2F1/MAPK3/MAPK1/STAT3/TFDP1/TP53",6
"R-HSA-4791275","R-HSA-4791275","Signaling by WNT in cancer","5/45","31/2914",8.8180502983625e-05,0.000600153871052731,0.000322797442186718,"PPP2CA/GSK3B/PPP2CB/AMER1/PPP2R1B",5
"R-HSA-168898","R-HSA-168898","Toll-like Receptor Cascades","9/45","127/2914",9.9899369231761e-05,0.000669913417201221,0.000360318158374618,"MAPK3/PPP2CA/MAPK1/RPS6KA2/MAPK9/RPS6KA3/PPP2CB/DUSP6/PPP2R1B",9
"R-HSA-373760","R-HSA-373760","L1CAM interactions","6/45","53/2914",0.000128290581422555,0.000845424477001285,0.000454718151295705,"MAPK3/MAPK1/CSNK2A1/RPS6KA2/RPS6KA3/CSNK2A2",6
"R-HSA-881907","R-HSA-881907","Gastrin-CREB signalling pathway via PKC and MAPK","4/45","18/2914",0.000129780073223881,0.000845424477001285,0.000454718151295705,"MAPK3/MAPK1/RPS6KA2/RPS6KA3",4
"R-HSA-1266738","R-HSA-1266738","Developmental Biology","16/45","397/2914",0.000153769865098955,0.000979959241560941,0.000527078724108262,"NOTCH1/E2F1/SMAD3/MAPK3/SMAD4/MAPK1/CSNK2A1/RPS6KA2/EP300/STAT3/PAX6/TFDP1/KDM6A/RPS6KA3/GSK3B/CSNK2A2",16
"R-HSA-68886","R-HSA-68886","M Phase","8/45","105/2914",0.000154730406562254,0.000979959241560941,0.000527078724108262,"MAPK3/PPP2CA/MAPK1/CSNK2A1/PPP2CB/CSNK2A2/SET/PPP2R1B",8
"R-HSA-1643685","R-HSA-1643685","Disease","17/45","443/2914",0.000161831863826115,0.00100160028292462,0.000538718527057795,"NOTCH1/SMAD3/MAPK3/PPP2CA/SMAD4/LCK/MAPK1/EP300/STAT3/NR4A1/GSK3B/PPP2CB/AMER1/FGF19/GSK3A/PPP2R1B/CAMK2A",17
"R-HSA-389513","R-HSA-389513","CTLA4 inhibitory signaling","4/45","19/2914",0.000162540396790399,0.00100160028292462,0.000538718527057795,"PPP2CA/LCK/PPP2CB/PPP2R1B",4
"R-HSA-201681","R-HSA-201681","TCF dependent signaling in response to WNT","8/45","108/2914",0.000188703990555603,0.00114732026257807,0.000617095155080077,"PPP2CA/CSNK2A1/EP300/GSK3B/PPP2CB/CSNK2A2/AMER1/PPP2R1B",8
"R-HSA-445144","R-HSA-445144","Signal transduction by L1","4/45","20/2914",0.000200892324806763,0.00120535394884058,0.000648309026038445,"MAPK3/MAPK1/CSNK2A1/CSNK2A2",4
"R-HSA-195253","R-HSA-195253","Degradation of beta-catenin by the destruction complex","5/45","37/2914",0.000211129741630947,0.00125032678160665,0.000672498015037741,"PPP2CA/GSK3B/PPP2CB/AMER1/PPP2R1B",5
"R-HSA-111885","R-HSA-111885","Opioid Signalling","6/45","59/2914",0.00023488255919941,0.00137315957685809,0.00073856459235442,"PPP2CA/MAPK1/PPP2CB/PRKCD/PPP2R1B/CAMK2A",6
"R-HSA-5654743","R-HSA-5654743","Signaling by FGFR4","5/45","38/2914",0.000240338164167352,0.00138726839063687,0.000746153127927954,"MAPK3/PPP2CA/MAPK1/PPP2CB/FGF19",5
"R-HSA-69206","R-HSA-69206","G1/S Transition","6/45","60/2914",0.000257974540030019,0.00147045487817111,0.00079089562930256,"E2F1/PPP2CA/MAX/TFDP1/PPP2CB/PPP2R1B",6
"R-HSA-69231","R-HSA-69231","Cyclin D associated events in G1","5/45","40/2914",0.000307899399795607,0.00171222105252191,0.000920931452533716,"E2F1/PPP2CA/TFDP1/PPP2CB/PPP2R1B",5
"R-HSA-69236","R-HSA-69236","G1 Phase","5/45","40/2914",0.000307899399795607,0.00171222105252191,0.000920931452533716,"E2F1/PPP2CA/TFDP1/PPP2CB/PPP2R1B",5
"R-HSA-450341","R-HSA-450341","Activation of the AP-1 family of transcription factors","3/45","10/2914",0.000383057084808407,0.00210450639364619,0.00113192518402484,"MAPK3/MAPK1/MAPK9",3
"R-HSA-2173796","R-HSA-2173796","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription","4/45","24/2914",0.000421131944731344,0.0022201797395206,0.00119414099563319,"SMAD3/SMAD4/SP1/TFDP1",4
"R-HSA-8941326","R-HSA-8941326","RUNX2 regulates bone development","4/45","24/2914",0.000421131944731344,0.0022201797395206,0.00119414099563319,"MAPK3/SMAD4/MAPK1/ZNF521",4
"R-HSA-982772","R-HSA-982772","Growth hormone receptor signaling","4/45","24/2914",0.000421131944731344,0.0022201797395206,0.00119414099563319,"MAPK3/MAPK1/STAT3/SOCS3",4
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","7/45","92/2914",0.000423586923987482,0.0022201797395206,0.00119414099563319,"MAPK3/PPP2CA/LCK/MAPK1/PPP2CB/FGF19/PPP2R1B",7
"R-HSA-69275","R-HSA-69275","G2/M Transition","6/45","66/2914",0.000436746500918034,0.00226314095930254,0.00121724802289356,"PPP2CA/EP300/TP53/PPP2CB/PPP1CB/PPP2R1B",6
"R-HSA-5633007","R-HSA-5633007","Regulation of TP53 Activity","7/45","95/2914",0.000516013089747201,0.00263984734614491,0.00141986249227093,"PPP2CA/CSNK2A1/EP300/TP53/PPP2CB/CSNK2A2/PPP2R1B",7
"R-HSA-1362277","R-HSA-1362277","Transcription of E2F targets under negative control by DREAM complex","3/45","11/2914",0.000521022502528602,0.00263984734614491,0.00141986249227093,"E2F1/MAX/TFDP1",3
"R-HSA-2559582","R-HSA-2559582","Senescence-Associated Secretory Phenotype (SASP)","5/45","45/2914",0.000539748298970538,0.00270467279484138,0.00145472936564645,"MAPK3/MAPK1/RPS6KA2/STAT3/RPS6KA3",5
"R-HSA-438064","R-HSA-438064","Post NMDA receptor activation events","5/45","47/2914",0.000662259117057129,0.00322747117653958,0.00173592055432531,"MAPK3/MAPK1/RPS6KA2/RPS6KA3/CAMK2A",5
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","7/45","99/2914",0.000663657138191693,0.00322747117653958,0.00173592055432531,"MAPK3/PPP2CA/LCK/MAPK1/PPP2CB/FGF19/PPP2R1B",7
"R-HSA-5654732","R-HSA-5654732","Negative regulation of FGFR3 signaling","4/45","27/2914",0.000672389828445747,0.00322747117653958,0.00173592055432531,"MAPK3/PPP2CA/MAPK1/PPP2CB",4
"R-HSA-9616222","R-HSA-9616222","Transcriptional regulation of granulopoiesis","4/45","27/2914",0.000672389828445747,0.00322747117653958,0.00173592055432531,"E2F1/EP300/STAT3/TFDP1",4
"R-HSA-109581","R-HSA-109581","Apoptosis","7/45","101/2914",0.000749156494267954,0.00355849334777278,0.00191396341189072,"E2F1/MAPK3/MAPK1/STAT3/TFDP1/TP53/PRKCD",7
"R-HSA-3371556","R-HSA-3371556","Cellular response to heat stress","5/45","49/2914",0.00080456286354153,0.00374368026300957,0.00201356763915335,"MAPK3/MAPK1/EP300/GSK3B/CAMK2A",5
"R-HSA-442755","R-HSA-442755","Activation of NMDA receptors and postsynaptic events","5/45","49/2914",0.00080456286354153,0.00374368026300957,0.00201356763915335,"MAPK3/MAPK1/RPS6KA2/RPS6KA3/CAMK2A",5
"R-HSA-5357801","R-HSA-5357801","Programmed Cell Death","7/45","103/2914",0.000843202670997489,0.00388384260580662,0.00208895504882951,"E2F1/MAPK3/MAPK1/STAT3/TFDP1/TP53/PRKCD",7
"R-HSA-5673000","R-HSA-5673000","RAF activation","4/45","29/2914",0.000889669356311945,0.00395620817799973,0.00212787743645876,"PPP2CA/PPP2CB/PPP2R1B/CAMK2A",4
"R-HSA-6804757","R-HSA-6804757","Regulation of TP53 Degradation","4/45","29/2914",0.000889669356311945,0.00395620817799973,0.00212787743645876,"PPP2CA/TP53/PPP2CB/PPP2R1B",4
"R-HSA-6806003","R-HSA-6806003","Regulation of TP53 Expression and Degradation","4/45","29/2914",0.000889669356311945,0.00395620817799973,0.00212787743645876,"PPP2CA/TP53/PPP2CB/PPP2R1B",4
"R-HSA-157118","R-HSA-157118","Signaling by NOTCH","7/45","104/2914",0.000893617198100816,0.00395620817799973,0.00212787743645876,"NOTCH1/E2F1/SMAD3/EP300/HIF1A/TFDP1/TP53",7
"R-HSA-195721","R-HSA-195721","Signaling by WNT","9/45","172/2914",0.000985863405966283,0.00428568946386668,0.00230509151680733,"PPP2CA/CSNK2A1/EP300/GSK3B/PPP2CB/CSNK2A2/AMER1/PPP2R1B/CAMK2A",9
"R-HSA-453279","R-HSA-453279","Mitotic G1-G1/S phases","6/45","77/2914",0.00100329985105999,0.00428568946386668,0.00230509151680733,"E2F1/PPP2CA/MAX/TFDP1/PPP2CB/PPP2R1B",6
"R-HSA-390466","R-HSA-390466","Chaperonin-mediated protein folding","4/45","30/2914",0.00101503171512632,0.00428568946386668,0.00230509151680733,"CSNK2A1/STAT3/TP53/CSNK2A2",4
"R-HSA-5654726","R-HSA-5654726","Negative regulation of FGFR1 signaling","4/45","30/2914",0.00101503171512632,0.00428568946386668,0.00230509151680733,"MAPK3/PPP2CA/MAPK1/PPP2CB",4
"R-HSA-6791312","R-HSA-6791312","TP53 Regulates Transcription of Cell Cycle Genes","4/45","30/2914",0.00101503171512632,0.00428568946386668,0.00230509151680733,"E2F1/EP300/TFDP1/TP53",4
"R-HSA-391251","R-HSA-391251","Protein folding","4/45","31/2914",0.00115234300581413,0.00479379211298426,0.00257837849105571,"CSNK2A1/STAT3/TP53/CSNK2A2",4
"R-HSA-8878159","R-HSA-8878159","Transcriptional regulation by RUNX3","5/45","53/2914",0.00115639722023743,0.00479379211298426,0.00257837849105571,"NOTCH1/SMAD3/SMAD4/EP300/TP53",5
"R-HSA-5654727","R-HSA-5654727","Negative regulation of FGFR2 signaling","4/45","32/2914",0.0013022042531777,0.00534959585089217,0.00287732186809297,"MAPK3/PPP2CA/MAPK1/PPP2CB",4
"R-HSA-190236","R-HSA-190236","Signaling by FGFR","5/45","55/2914",0.00136999430003396,0.00550335706302638,0.00296002353574595,"MAPK3/PPP2CA/MAPK1/PPP2CB/FGF19",5
"R-HSA-432142","R-HSA-432142","Platelet sensitization by LDL","3/45","15/2914",0.0013758392657566,0.00550335706302638,0.00296002353574595,"PPP2CA/PPP2CB/PPP2R1B",3
"R-HSA-6804114","R-HSA-6804114","TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest","3/45","15/2914",0.0013758392657566,0.00550335706302638,0.00296002353574595,"EP300/TFDP1/TP53",3
"R-HSA-68877","R-HSA-68877","Mitotic Prometaphase","5/45","56/2914",0.00148712684537133,0.00589678123034195,0.00317162979378965,"PPP2CA/CSNK2A1/PPP2CB/CSNK2A2/PPP2R1B",5
"R-HSA-5668599","R-HSA-5668599","RHO GTPases Activate NADPH Oxidases","3/45","16/2914",0.00167512026873237,0.00658495553915484,0.00354176971519639,"MAPK3/MAPK1/PRKCD",3
"R-HSA-6807070","R-HSA-6807070","PTEN Regulation","5/45","59/2914",0.00188307269098417,0.0073391551033229,0.00394742183535142,"MAPK3/MAPK1/CSNK2A1/TP53/CSNK2A2",5
"R-HSA-9013695","R-HSA-9013695","NOTCH4 Intracellular Domain Regulates Transcription","3/45","17/2914",0.00201219866545871,0.0077759541648235,0.00418235761866084,"NOTCH1/SMAD3/EP300",3
"R-HSA-2173793","R-HSA-2173793","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer","4/45","36/2914",0.00203913029801114,0.0078138102175889,0.0042027187920088,"SMAD3/SMAD4/SP1/TFDP1",4
"R-HSA-5654741","R-HSA-5654741","Signaling by FGFR3","4/45","37/2914",0.00226070612302693,0.00859068326750232,0.00462056602337959,"MAPK3/PPP2CA/MAPK1/PPP2CB",4
"R-HSA-3700989","R-HSA-3700989","Transcriptional Regulation by TP53","9/45","194/2914",0.00231457253430284,0.00871391333648791,0.00468684627747388,"E2F1/PPP2CA/CSNK2A1/EP300/TFDP1/TP53/PPP2CB/CSNK2A2/PPP2R1B",9
"R-HSA-8878166","R-HSA-8878166","Transcriptional regulation by RUNX2","5/45","62/2914",0.00235156007158935,0.00871391333648791,0.00468684627747388,"MAPK3/SMAD4/MAPK1/ZNF521/GSK3B",5
"R-HSA-69273","R-HSA-69273","Cyclin A/B1/B2 associated events during G2/M transition","3/45","18/2914",0.00238868238390568,0.00871391333648791,0.00468684627747388,"PPP2CA/PPP2CB/PPP2R1B",3
"R-HSA-8939243","R-HSA-8939243","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known","3/45","18/2914",0.00238868238390568,0.00871391333648791,0.00468684627747388,"CSNK2A1/EP300/CSNK2A2",3
"R-HSA-8953750","R-HSA-8953750","Transcriptional Regulation by E2F6","3/45","18/2914",0.00238868238390568,0.00871391333648791,0.00468684627747388,"E2F1/MAX/TFDP1",3
"R-HSA-170834","R-HSA-170834","Signaling by TGF-beta Receptor Complex","5/45","63/2914",0.00252512928273814,0.0091385631184809,0.00491524747600658,"SMAD3/SMAD4/SP1/TFDP1/PPP1CB",5
"R-HSA-1538133","R-HSA-1538133","G0 and Early G1","3/45","19/2914",0.0028060840064898,0.0099966742731199,0.00537678925585627,"E2F1/MAX/TFDP1",3
"R-HSA-8940973","R-HSA-8940973","RUNX2 regulates osteoblast differentiation","3/45","19/2914",0.0028060840064898,0.0099966742731199,0.00537678925585627,"MAPK3/MAPK1/ZNF521",3
"R-HSA-437239","R-HSA-437239","Recycling pathway of L1","3/45","20/2914",0.00326582371502209,0.0113485825252236,0.0061039236573802,"MAPK1/RPS6KA2/RPS6KA3",3
"R-HSA-70171","R-HSA-70171","Glycolysis","3/45","20/2914",0.00326582371502209,0.0113485825252236,0.0061039236573802,"PPP2CA/PPP2CB/PPP2R1B",3
"R-HSA-70326","R-HSA-70326","Glucose metabolism","3/45","20/2914",0.00326582371502209,0.0113485825252236,0.0061039236573802,"PPP2CA/PPP2CB/PPP2R1B",3
"R-HSA-195258","R-HSA-195258","RHO GTPase Effectors","7/45","130/2914",0.00328511599414368,0.0113485825252236,0.0061039236573802,"MAPK3/PPP2CA/MAPK1/PPP2CB/PPP1CB/PRKCD/PPP2R1B",7
"R-HSA-5654736","R-HSA-5654736","Signaling by FGFR1","4/45","41/2914",0.00331392482245081,0.0113620279626885,0.00611115539082737,"MAPK3/PPP2CA/MAPK1/PPP2CB",4
"R-HSA-180024","R-HSA-180024","DARPP-32 events","3/45","22/2914",0.00431755329049663,0.0146925694064661,0.00790251309258221,"PPP2CA/PPP2CB/PPP2R1B",3
"R-HSA-9006934","R-HSA-9006934","Signaling by Receptor Tyrosine Kinases","12/45","347/2914",0.0049529258576337,0.0167298828968961,0.00899829804934622,"MAPK3/PPP2CA/LCK/MAPK1/RPS6KA2/STAT3/RPS6KA3/PPP2CB/PRKCD/FGF19/DUSP6/PPP2R1B",12
"R-HSA-186712","R-HSA-186712","Regulation of beta-cell development","3/45","24/2914",0.00555349205557088,0.018484615892995,0.00994209488242808,"NOTCH1/EP300/PAX6",3
"R-HSA-5674400","R-HSA-5674400","Constitutive Signaling by AKT1 E17K in Cancer","3/45","24/2914",0.00555349205557088,0.018484615892995,0.00994209488242808,"NR4A1/GSK3B/GSK3A",3
"R-HSA-112314","R-HSA-112314","Neurotransmitter receptors and postsynaptic signal transmission","5/45","77/2914",0.00604516204793779,0.0199753180714466,0.010743880680164,"MAPK3/MAPK1/RPS6KA2/RPS6KA3/CAMK2A",5
"R-HSA-5654738","R-HSA-5654738","Signaling by FGFR2","4/45","50/2914",0.00681176944298074,0.0223465242158217,0.0120192524060168,"MAPK3/PPP2CA/MAPK1/PPP2CB",4
"R-HSA-111996","R-HSA-111996","Ca-dependent events","3/45","26/2914",0.00698195942479396,0.0227412392693289,0.0122315529772706,"MAPK1/PRKCD/CAMK2A",3
"R-HSA-5689880","R-HSA-5689880","Ub-specific processing proteases","5/45","80/2914",0.00710684932379248,0.022983853132265,0.0123620447364214,"SMAD3/SMAD4/GATA3/HIF1A/TP53",5
"R-HSA-5617472","R-HSA-5617472","Activation of anterior HOX genes in hindbrain development during early embryogenesis","3/45","27/2914",0.00777065562433748,0.024779153599286,0.0133276611002623,"EP300/PAX6/KDM6A",3
"R-HSA-5619507","R-HSA-5619507","Activation of HOX genes during differentiation","3/45","27/2914",0.00777065562433748,0.024779153599286,0.0133276611002623,"EP300/PAX6/KDM6A",3
"R-HSA-388841","R-HSA-388841","Costimulation by the CD28 family","4/45","53/2914",0.00837463721052307,0.0265196844999897,0.0142638192255254,"PPP2CA/LCK/PPP2CB/PPP2R1B",4
"R-HSA-2173789","R-HSA-2173789","TGF-beta receptor signaling activates SMADs","3/45","28/2914",0.008610055673772,0.0270771406016554,0.0145636513393022,"SMAD3/SMAD4/PPP1CB",3
"R-HSA-114452","R-HSA-114452","Activation of BH3-only proteins","3/45","29/2914",0.00950086947963277,0.0283554115435346,0.0152511793389741,"E2F1/TFDP1/TP53",3
"R-HSA-141424","R-HSA-141424","Amplification of signal from the kinetochores","3/45","29/2914",0.00950086947963277,0.0283554115435346,0.0152511793389741,"PPP2CA/PPP2CB/PPP2R1B",3
"R-HSA-141444","R-HSA-141444","Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal","3/45","29/2914",0.00950086947963277,0.0283554115435346,0.0152511793389741,"PPP2CA/PPP2CB/PPP2R1B",3
"R-HSA-8878171","R-HSA-8878171","Transcriptional regulation by RUNX1","5/45","86/2914",0.00961201250522667,0.0283554115435346,0.0152511793389741,"CSNK2A1/GATA3/EP300/SOCS3/CSNK2A2",5
"R-HSA-9006936","R-HSA-9006936","Signaling by TGF-beta family members","5/45","86/2914",0.00961201250522667,0.0283554115435346,0.0152511793389741,"SMAD3/SMAD4/SP1/TFDP1/PPP1CB",5
"R-HSA-111458","R-HSA-111458","Formation of apoptosome","2/45","10/2914",0.00970053552805132,0.0283554115435346,0.0152511793389741,"MAPK3/MAPK1",2
"R-HSA-1362300","R-HSA-1362300","Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1","2/45","10/2914",0.00970053552805132,0.0283554115435346,0.0152511793389741,"E2F1/TFDP1",2
"R-HSA-5250924","R-HSA-5250924","B-WICH complex positively regulates rRNA expression","2/45","10/2914",0.00970053552805132,0.0283554115435346,0.0152511793389741,"EP300/GSK3B",2
"R-HSA-74749","R-HSA-74749","Signal attenuation","2/45","10/2914",0.00970053552805132,0.0283554115435346,0.0152511793389741,"MAPK3/MAPK1",2
"R-HSA-8934903","R-HSA-8934903","Receptor Mediated Mitophagy","2/45","10/2914",0.00970053552805132,0.0283554115435346,0.0152511793389741,"CSNK2A1/CSNK2A2",2
"R-HSA-9627069","R-HSA-9627069","Regulation of the apoptosome activity","2/45","10/2914",0.00970053552805132,0.0283554115435346,0.0152511793389741,"MAPK3/MAPK1",2
"R-HSA-168249","R-HSA-168249","Innate Immune System","13/45","428/2914",0.0101403089886475,0.0294521076358168,0.0158410458890705,"MAPK3/PPP2CA/LCK/MAPK1/RPS6KA2/EP300/MAPK9/RPS6KA3/PTPRB/PPP2CB/PRKCD/DUSP6/PPP2R1B",13
"R-HSA-2871796","R-HSA-2871796","FCERI mediated MAPK activation","3/45","30/2914",0.0104437403423557,0.0301414278235077,0.0162118021303723,"MAPK3/MAPK1/MAPK9",3
"R-HSA-112315","R-HSA-112315","Transmission across Chemical Synapses","5/45","88/2914",0.0105678031095682,0.0303076617481956,0.0163012123437894,"MAPK3/MAPK1/RPS6KA2/RPS6KA3/CAMK2A",5
"R-HSA-5688426","R-HSA-5688426","Deubiquitination","6/45","124/2914",0.0109638404371607,0.0312469452459079,0.0168064133017003,"SMAD3/SMAD4/GATA3/EP300/HIF1A/TP53",6
"R-HSA-1059683","R-HSA-1059683","Interleukin-6 signaling","2/45","11/2914",0.0117404273115008,0.0326441149636852,0.0175578919356848,"STAT3/SOCS3",2
"R-HSA-2586552","R-HSA-2586552","Signaling by Leptin","2/45","11/2914",0.0117404273115008,0.0326441149636852,0.0175578919356848,"STAT3/SOCS3",2
"R-HSA-452723","R-HSA-452723","Transcriptional regulation of pluripotent stem cells","2/45","11/2914",0.0117404273115008,0.0326441149636852,0.0175578919356848,"SMAD4/STAT3",2
"R-HSA-6804116","R-HSA-6804116","TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest","2/45","11/2914",0.0117404273115008,0.0326441149636852,0.0175578919356848,"E2F1/TP53",2
"R-HSA-3371453","R-HSA-3371453","Regulation of HSF1-mediated heat shock response","3/45","32/2914",0.0124879068150145,0.0343041295641363,0.0184507437406365,"MAPK3/MAPK1/GSK3B",3
"R-HSA-8943724","R-HSA-8943724","Regulation of PTEN gene transcription","3/45","32/2914",0.0124879068150145,0.0343041295641363,0.0184507437406365,"MAPK3/MAPK1/TP53",3
"R-HSA-6785807","R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","5/45","94/2914",0.013825069063163,0.0369865611685278,0.0198935105084649,"GATA3/HIF1A/STAT3/SOCS3/TP53",5
"R-HSA-111461","R-HSA-111461","Cytochrome c-mediated apoptotic response","2/45","12/2914",0.0139510713179535,0.0369865611685278,0.0198935105084649,"MAPK3/MAPK1",2
"R-HSA-1483206","R-HSA-1483206","Glycerophospholipid biosynthesis","2/45","12/2914",0.0139510713179535,0.0369865611685278,0.0198935105084649,"CSNK2A1/CSNK2A2",2
"R-HSA-1502540","R-HSA-1502540","Signaling by Activin","2/45","12/2914",0.0139510713179535,0.0369865611685278,0.0198935105084649,"SMAD3/SMAD4",2
"R-HSA-170968","R-HSA-170968","Frs2-mediated activation","2/45","12/2914",0.0139510713179535,0.0369865611685278,0.0198935105084649,"MAPK3/MAPK1",2
"R-HSA-210744","R-HSA-210744","Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells","2/45","12/2914",0.0139510713179535,0.0369865611685278,0.0198935105084649,"NOTCH1/EP300",2
"R-HSA-112040","R-HSA-112040","G-protein mediated events","3/45","34/2914",0.0147464532379448,0.038206719752857,0.0205497823232125,"MAPK1/PRKCD/CAMK2A",3
"R-HSA-112043","R-HSA-112043","PLC beta mediated events","3/45","34/2914",0.0147464532379448,0.038206719752857,0.0205497823232125,"MAPK1/PRKCD/CAMK2A",3
"R-HSA-2500257","R-HSA-2500257","Resolution of Sister Chromatid Cohesion","3/45","34/2914",0.0147464532379448,0.038206719752857,0.0205497823232125,"PPP2CA/PPP2CB/PPP2R1B",3
"R-HSA-5674135","R-HSA-5674135","MAP2K and MAPK activation","3/45","34/2914",0.0147464532379448,0.038206719752857,0.0205497823232125,"MAPK3/MAPK1/WDR83",3
"R-HSA-2219528","R-HSA-2219528","PI3K/AKT Signaling in Cancer","5/45","97/2914",0.0156845353087155,0.0404076163885553,0.0217335517510004,"LCK/NR4A1/GSK3B/FGF19/GSK3A",5
"R-HSA-169893","R-HSA-169893","Prolonged ERK activation events","2/45","13/2914",0.0163269492257719,0.0411330875522209,0.0221237520767947,"MAPK3/MAPK1",2
"R-HSA-198323","R-HSA-198323","AKT phosphorylates targets in the cytosol","2/45","13/2914",0.0163269492257719,0.0411330875522209,0.0221237520767947,"GSK3B/GSK3A",2
"R-HSA-6804760","R-HSA-6804760","Regulation of TP53 Activity through Methylation","2/45","13/2914",0.0163269492257719,0.0411330875522209,0.0221237520767947,"EP300/TP53",2
"R-HSA-8941856","R-HSA-8941856","RUNX3 regulates NOTCH signaling","2/45","13/2914",0.0163269492257719,0.0411330875522209,0.0221237520767947,"NOTCH1/EP300",2
"R-HSA-6804758","R-HSA-6804758","Regulation of TP53 Activity through Acetylation","2/45","14/2914",0.0188626658690869,0.047002052657397,0.0252804207506313,"EP300/TP53",2
"R-HSA-9617828","R-HSA-9617828","FOXO-mediated transcription of cell cycle genes","2/45","14/2914",0.0188626658690869,0.047002052657397,0.0252804207506313,"SMAD3/SMAD4",2
"R-HSA-69202","R-HSA-69202","Cyclin E associated events during G1/S transition ","3/45","39/2914",0.0213481135828355,0.0520007607383739,0.0279690148939084,"E2F1/MAX/TFDP1",3
"R-HSA-112316","R-HSA-112316","Neuronal System","5/45","105/2914",0.0214487881208747,0.0520007607383739,0.0279690148939084,"MAPK3/MAPK1/RPS6KA2/RPS6KA3/CAMK2A",5
"R-HSA-1181150","R-HSA-1181150","Signaling by NODAL","2/45","15/2914",0.0215529468849839,0.0520007607383739,0.0279690148939084,"SMAD3/SMAD4",2
"R-HSA-5250913","R-HSA-5250913","Positive epigenetic regulation of rRNA expression","2/45","15/2914",0.0215529468849839,0.0520007607383739,0.0279690148939084,"EP300/GSK3B",2
"R-HSA-69205","R-HSA-69205","G1/S-Specific Transcription","2/45","15/2914",0.0215529468849839,0.0520007607383739,0.0279690148939084,"E2F1/TFDP1",2
"R-HSA-9008059","R-HSA-9008059","Interleukin-37 signaling","2/45","15/2914",0.0215529468849839,0.0520007607383739,0.0279690148939084,"SMAD3/STAT3",2
"R-HSA-69242","R-HSA-69242","S Phase","4/45","71/2914",0.0227237601819798,0.0539493299003435,0.0290170680211912,"E2F1/MAX/TFDP1/GSK3B",4
"R-HSA-2122947","R-HSA-2122947","NOTCH1 Intracellular Domain Regulates Transcription","3/45","40/2914",0.0228338172604524,0.0539493299003435,0.0290170680211912,"NOTCH1/EP300/HIF1A",3
"R-HSA-69656","R-HSA-69656","Cyclin A:Cdk2-associated events at S phase entry","3/45","40/2914",0.0228338172604524,0.0539493299003435,0.0290170680211912,"E2F1/MAX/TFDP1",3
"R-HSA-9013694","R-HSA-9013694","Signaling by NOTCH4","3/45","40/2914",0.0228338172604524,0.0539493299003435,0.0290170680211912,"NOTCH1/SMAD3/EP300",3
"R-HSA-8939211","R-HSA-8939211","ESR-mediated signaling","5/45","108/2914",0.0239273046343212,0.0562414995528374,0.0302499293532113,"MAPK3/MAPK1/GATA3/EP300/SP1",5
"R-HSA-111471","R-HSA-111471","Apoptotic factor-mediated response","2/45","16/2914",0.0243926364015913,0.0567502153016613,0.0305235460879203,"MAPK3/MAPK1",2
"R-HSA-5205647","R-HSA-5205647","Mitophagy","2/45","16/2914",0.0243926364015913,0.0567502153016613,0.0305235460879203,"CSNK2A1/CSNK2A2",2
"R-HSA-418346","R-HSA-418346","Platelet homeostasis","3/45","42/2914",0.025971249829754,0.0586281679325139,0.0315336175629634,"PPP2CA/PPP2CB/PPP2R1B",3
"R-HSA-6802946","R-HSA-6802946","Signaling by moderate kinase activity BRAF mutants","3/45","42/2914",0.025971249829754,0.0586281679325139,0.0315336175629634,"MAPK3/MAPK1/CAMK2A",3
"R-HSA-6802949","R-HSA-6802949","Signaling by RAS mutants","3/45","42/2914",0.025971249829754,0.0586281679325139,0.0315336175629634,"MAPK3/MAPK1/CAMK2A",3
"R-HSA-6802955","R-HSA-6802955","Paradoxical activation of RAF signaling by kinase inactive BRAF","3/45","42/2914",0.025971249829754,0.0586281679325139,0.0315336175629634,"MAPK3/MAPK1/CAMK2A",3
"R-HSA-69618","R-HSA-69618","Mitotic Spindle Checkpoint","3/45","42/2914",0.025971249829754,0.0586281679325139,0.0315336175629634,"PPP2CA/PPP2CB/PPP2R1B",3
"R-HSA-9649948","R-HSA-9649948","Signaling downstream of RAS mutants","3/45","42/2914",0.025971249829754,0.0586281679325139,0.0315336175629634,"MAPK3/MAPK1/CAMK2A",3
"R-HSA-71387","R-HSA-71387","Metabolism of carbohydrates","3/45","44/2914",0.0293298690467889,0.0658838437701267,0.035436139423914,"PPP2CA/PPP2CB/PPP2R1B",3
"R-HSA-9013508","R-HSA-9013508","NOTCH3 Intracellular Domain Regulates Transcription","2/45","18/2914",0.0305001963142219,0.0681769094082607,0.0366694826688013,"NOTCH1/EP300",2
"R-HSA-6802952","R-HSA-6802952","Signaling by BRAF and RAF fusions","3/45","46/2914",0.0329089043816013,0.0732022458439521,0.0393723990804267,"MAPK3/MAPK1/CAMK2A",3
"R-HSA-3371571","R-HSA-3371571","HSF1-dependent transactivation","2/45","19/2914",0.0337583271739551,0.0740086403429015,0.0398061246534996,"EP300/CAMK2A",2
"R-HSA-6814122","R-HSA-6814122","Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding","2/45","19/2914",0.0337583271739551,0.0740086403429015,0.0398061246534996,"CSNK2A1/CSNK2A2",2
"R-HSA-9615017","R-HSA-9615017","FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes","2/45","19/2914",0.0337583271739551,0.0740086403429015,0.0398061246534996,"SMAD3/SMAD4",2
"R-HSA-556833","R-HSA-556833","Metabolism of lipids","5/45","119/2914",0.0345857389810445,0.0744600364082212,0.0400489115492048,"CSNK2A1/EP300/SP1/CSNK2A2/PPP1CB",5
"R-HSA-5663220","R-HSA-5663220","RHO GTPases Activate Formins","3/45","47/2914",0.0347806749012086,0.0744600364082212,0.0400489115492048,"PPP2CA/PPP2CB/PPP2R1B",3
"R-HSA-877300","R-HSA-877300","Interferon gamma signaling","3/45","47/2914",0.0347806749012086,0.0744600364082212,0.0400489115492048,"SOCS3/PRKCD/CAMK2A",3
"R-HSA-8848021","R-HSA-8848021","Signaling by PTK6","3/45","47/2914",0.0347806749012086,0.0744600364082212,0.0400489115492048,"HIF1A/STAT3/SOCS3",3
"R-HSA-9006927","R-HSA-9006927","Signaling by Non-Receptor Tyrosine Kinases","3/45","47/2914",0.0347806749012086,0.0744600364082212,0.0400489115492048,"HIF1A/STAT3/SOCS3",3
"R-HSA-109582","R-HSA-109582","Hemostasis","9/45","298/2914",0.0350693608401521,0.0747272361827539,0.040192627032737,"MAPK3/PPP2CA/LCK/MAPK1/GATA3/TP53/PPP2CB/PRKCD/PPP2R1B",9
"R-HSA-2173795","R-HSA-2173795","Downregulation of SMAD2/3:SMAD4 transcriptional activity","2/45","20/2914",0.0371463831138365,0.078784886976323,0.0423750661714757,"SMAD3/SMAD4",2
"R-HSA-6802957","R-HSA-6802957","Oncogenic MAPK signaling","3/45","49/2914",0.0386876136383727,0.0809245496288896,0.0435259004236641,"MAPK3/MAPK1/CAMK2A",3
"R-HSA-9018519","R-HSA-9018519","Estrogen-dependent gene expression","3/45","49/2914",0.0386876136383727,0.0809245496288896,0.0435259004236641,"GATA3/EP300/SP1",3
"R-HSA-9614085","R-HSA-9614085","FOXO-mediated transcription","3/45","49/2914",0.0386876136383727,0.0809245496288896,0.0435259004236641,"SMAD3/SMAD4/EP300",3
"R-HSA-2173788","R-HSA-2173788","Downregulation of TGF-beta receptor signaling","2/45","22/2914",0.0442939888376182,0.0922285794975064,0.0496058610870706,"SMAD3/PPP1CB",2
"R-HSA-400253","R-HSA-400253","Circadian Clock","3/45","52/2914",0.0449522414739651,0.0923343338384148,0.049662741884466,"EP300/HIF1A/PPP1CB",3
"R-HSA-74751","R-HSA-74751","Insulin receptor signalling cascade","3/45","52/2914",0.0449522414739651,0.0923343338384148,0.049662741884466,"MAPK3/MAPK1/FGF19",3
"R-HSA-74752","R-HSA-74752","Signaling by Insulin receptor","3/45","52/2914",0.0449522414739651,0.0923343338384148,0.049662741884466,"MAPK3/MAPK1/FGF19",3
"R-HSA-6783589","R-HSA-6783589","Interleukin-6 family signaling","2/45","23/2914",0.048044659484847,0.0982437880048889,0.0528411879158336,"STAT3/SOCS3",2
"R-HSA-163685","R-HSA-163685","Integration of energy metabolism","3/45","55/2914",0.0516935389310587,0.104733702463291,0.0563318390441987,"PPP2CA/PPP2CB/PPP2R1B",3
"R-HSA-1234174","R-HSA-1234174","Cellular response to hypoxia","2/45","24/2914",0.0519074928875084,0.104733702463291,0.0563318390441987,"EP300/HIF1A",2
"R-HSA-9634638","R-HSA-9634638","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","2/45","24/2914",0.0519074928875084,0.104733702463291,0.0563318390441987,"MAPK3/MAPK1",2
"R-HSA-2467813","R-HSA-2467813","Separation of Sister Chromatids","3/45","56/2914",0.0540446562587186,0.108089312517437,0.0581366800936354,"PPP2CA/PPP2CB/PPP2R1B",3
"R-HSA-6804756","R-HSA-6804756","Regulation of TP53 Activity through Phosphorylation","3/45","56/2914",0.0540446562587186,0.108089312517437,0.0581366800936354,"CSNK2A1/TP53/CSNK2A2",3
"R-HSA-111933","R-HSA-111933","Calmodulin induced events","2/45","25/2914",0.055878301985403,0.109358393585166,0.0588192652477926,"PRKCD/CAMK2A",2
"R-HSA-111997","R-HSA-111997","CaM pathway","2/45","25/2914",0.055878301985403,0.109358393585166,0.0588192652477926,"PRKCD/CAMK2A",2
"R-HSA-456926","R-HSA-456926","Thrombin signalling through proteinase activated receptors (PARs)","2/45","25/2914",0.055878301985403,0.109358393585166,0.0588192652477926,"MAPK3/MAPK1",2
"R-HSA-5663213","R-HSA-5663213","RHO GTPases Activate WASPs and WAVEs","2/45","25/2914",0.055878301985403,0.109358393585166,0.0588192652477926,"MAPK3/MAPK1",2
"R-HSA-8948751","R-HSA-8948751","Regulation of PTEN stability and activity","2/45","25/2914",0.055878301985403,0.109358393585166,0.0588192652477926,"CSNK2A1/CSNK2A2",2
"R-HSA-9006931","R-HSA-9006931","Signaling by Nuclear Receptors","5/45","136/2914",0.056187541893064,0.109493671381356,0.0588920254659645,"MAPK3/MAPK1/GATA3/EP300/SP1",5
"R-HSA-194315","R-HSA-194315","Signaling by Rho GTPases","7/45","228/2914",0.0575759065659216,0.111721759123661,0.0600904198425968,"MAPK3/PPP2CA/MAPK1/PPP2CB/PPP1CB/PRKCD/PPP2R1B",7
"R-HSA-913531","R-HSA-913531","Interferon Signaling","4/45","97/2914",0.0607217984798788,0.117326864859427,0.0631051696958597,"MAPK3/SOCS3/PRKCD/CAMK2A",4
"R-HSA-68882","R-HSA-68882","Mitotic Anaphase","3/45","60/2914",0.0639566040139223,0.12305574443185,0.066186492272902,"PPP2CA/PPP2CB/PPP2R1B",3
"R-HSA-2555396","R-HSA-2555396","Mitotic Metaphase and Anaphase","3/45","61/2914",0.0665588632396884,0.127524544694529,0.0685900713615542,"PPP2CA/PPP2CB/PPP2R1B",3
"R-HSA-2029480","R-HSA-2029480","Fcgamma receptor (FCGR) dependent phagocytosis","3/45","62/2914",0.0692097272823041,0.13204868468925,0.0710234153568679,"MAPK3/MAPK1/PRKCD",3
"R-HSA-1430728","R-HSA-1430728","Metabolism","8/45","289/2914",0.0712989126763387,0.135467934085043,0.0728624853227496,"PPP2CA/CSNK2A1/EP300/SP1/PPP2CB/CSNK2A2/PPP1CB/PPP2R1B",8
"R-HSA-1980143","R-HSA-1980143","Signaling by NOTCH1","3/45","64/2914",0.0746549265647729,0.141255794661977,0.075975531293261,"NOTCH1/EP300/HIF1A",3
"R-HSA-1483257","R-HSA-1483257","Phospholipid metabolism","2/45","30/2914",0.0772121537607593,0.144891942859696,0.0779312619720897,"CSNK2A1/CSNK2A2",2
"R-HSA-1489509","R-HSA-1489509","DAG and IP3 signaling","2/45","30/2914",0.0772121537607593,0.144891942859696,0.0779312619720897,"PRKCD/CAMK2A",2
"R-HSA-450531","R-HSA-450531","Regulation of mRNA stability by proteins that bind AU-rich elements","2/45","31/2914",0.0817482162822018,0.152775355019197,0.0821714167116178,"PRKCD/SET",2
"R-HSA-375165","R-HSA-375165","NCAM signaling for neurite out-growth","2/45","32/2914",0.086365570246681,0.160092276554823,0.0861068800491086,"MAPK3/MAPK1",2
"R-HSA-6802948","R-HSA-6802948","Signaling by high-kinase activity BRAF mutants","2/45","32/2914",0.086365570246681,0.160092276554823,0.0861068800491086,"MAPK3/MAPK1",2
"R-HSA-187687","R-HSA-187687","Signalling to ERKs","2/45","33/2914",0.0910607569781734,0.168112166728936,0.0904204405536519,"MAPK3/MAPK1",2
"R-HSA-422475","R-HSA-422475","Axon guidance","7/45","254/2914",0.0915215768093272,0.168281608971989,0.0905115763861342,"MAPK3/MAPK1/CSNK2A1/RPS6KA2/RPS6KA3/GSK3B/CSNK2A2",7
"R-HSA-69620","R-HSA-69620","Cell Cycle Checkpoints","4/45","114/2914",0.096981828427246,0.17760527615592,0.0955263835279996,"PPP2CA/TP53/PPP2CB/PPP2R1B",4
"R-HSA-416476","R-HSA-416476","G alpha (q) signalling events","5/45","165/2914",0.107831072020733,0.196683875365817,0.105787956971919,"MAPK3/MAPK1/RPS6KA2/RPS6KA3/PRKCD",5
"R-HSA-212165","R-HSA-212165","Epigenetic regulation of gene expression","2/45","37/2914",0.110553534254403,0.200049252460348,0.107598051300233,"EP300/GSK3B",2
"R-HSA-9012852","R-HSA-9012852","Signaling by NOTCH3","2/45","37/2914",0.110553534254403,0.200049252460348,0.107598051300233,"NOTCH1/EP300",2
"R-HSA-418594","R-HSA-418594","G alpha (i) signalling events","6/45","217/2914",0.113694223110379,0.204919232167323,0.110217407883163,"PPP2CA/MAPK1/PPP2CB/PRKCD/PPP2R1B/CAMK2A",6
"R-HSA-1433557","R-HSA-1433557","Signaling by SCF-KIT","2/45","41/2914",0.131035883675565,0.234322991984539,0.12603244952077,"LCK/STAT3",2
"R-HSA-451927","R-HSA-451927","Interleukin-2 family signaling","2/45","41/2914",0.131035883675565,0.234322991984539,0.12603244952077,"LCK/STAT3",2
"R-HSA-2029482","R-HSA-2029482","Regulation of actin dynamics for phagocytic cup formation","2/45","43/2914",0.141589904171566,0.249303133770786,0.134089635661572,"MAPK3/MAPK1",2
"R-HSA-110056","R-HSA-110056","MAPK3 (ERK1) activation","1/45","10/2914",0.144333393235718,0.249303133770786,0.134089635661572,"MAPK3",1
"R-HSA-114508","R-HSA-114508","Effects of PIP2 hydrolysis","1/45","10/2914",0.144333393235718,0.249303133770786,0.134089635661572,"PRKCD",1
"R-HSA-164938","R-HSA-164938","Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters","1/45","10/2914",0.144333393235718,0.249303133770786,0.134089635661572,"LCK",1
"R-HSA-381038","R-HSA-381038","XBP1(S) activates chaperone genes","1/45","10/2914",0.144333393235718,0.249303133770786,0.134089635661572,"GSK3A",1
"R-HSA-6804759","R-HSA-6804759","Regulation of TP53 Activity through Association with Co-factors","1/45","10/2914",0.144333393235718,0.249303133770786,0.134089635661572,"TP53",1
"R-HSA-9020956","R-HSA-9020956","Interleukin-27 signaling","1/45","10/2914",0.144333393235718,0.249303133770786,0.134089635661572,"STAT3",1
"R-HSA-9020958","R-HSA-9020958","Interleukin-21 signaling","1/45","10/2914",0.144333393235718,0.249303133770786,0.134089635661572,"STAT3",1
"R-HSA-9617629","R-HSA-9617629","Regulation of FOXO transcriptional activity by acetylation","1/45","10/2914",0.144333393235718,0.249303133770786,0.134089635661572,"EP300",1
"R-HSA-2454202","R-HSA-2454202","Fc epsilon receptor (FCERI) signaling","3/45","87/2914",0.149366683399708,0.257023425019875,0.138242054546701,"MAPK3/MAPK1/MAPK9",3
"R-HSA-210745","R-HSA-210745","Regulation of gene expression in beta cells","1/45","11/2914",0.15759268982814,0.260370531020405,0.140042321624548,"PAX6",1
"R-HSA-210990","R-HSA-210990","PECAM1 interactions","1/45","11/2914",0.15759268982814,0.260370531020405,0.140042321624548,"LCK",1
"R-HSA-2197563","R-HSA-2197563","NOTCH2 intracellular domain regulates transcription","1/45","11/2914",0.15759268982814,0.260370531020405,0.140042321624548,"EP300",1
"R-HSA-3371568","R-HSA-3371568","Attenuation phase","1/45","11/2914",0.15759268982814,0.260370531020405,0.140042321624548,"EP300",1
"R-HSA-349425","R-HSA-349425","Autodegradation of the E3 ubiquitin ligase COP1","1/45","11/2914",0.15759268982814,0.260370531020405,0.140042321624548,"TP53",1
"R-HSA-438066","R-HSA-438066","Unblocking of NMDA receptors, glutamate binding and activation","1/45","11/2914",0.15759268982814,0.260370531020405,0.140042321624548,"CAMK2A",1
"R-HSA-5576892","R-HSA-5576892","Phase 0 - rapid depolarisation","1/45","11/2914",0.15759268982814,0.260370531020405,0.140042321624548,"CAMK2A",1
"R-HSA-5627117","R-HSA-5627117","RHO GTPases Activate ROCKs","1/45","11/2914",0.15759268982814,0.260370531020405,0.140042321624548,"PPP1CB",1
"R-HSA-6803207","R-HSA-6803207","TP53 Regulates Transcription of Caspase Activators and Caspases","1/45","11/2914",0.15759268982814,0.260370531020405,0.140042321624548,"TP53",1
"R-HSA-75815","R-HSA-75815","Ubiquitin-dependent degradation of Cyclin D","1/45","11/2914",0.15759268982814,0.260370531020405,0.140042321624548,"GSK3B",1
"R-HSA-8984722","R-HSA-8984722","Interleukin-35 Signalling","1/45","11/2914",0.15759268982814,0.260370531020405,0.140042321624548,"STAT3",1
"R-HSA-1989781","R-HSA-1989781","PPARA activates gene expression","2/45","47/2914",0.163217021537313,0.268689392855648,0.144516686369728,"EP300/SP1",2
"R-HSA-400206","R-HSA-400206","Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)","2/45","48/2914",0.16871745742546,0.270197446407385,0.145327804738967,"EP300/SP1",2
"R-HSA-111932","R-HSA-111932","CaMK IV-mediated phosphorylation of CREB","1/45","12/2914",0.170651018783611,0.270197446407385,0.145327804738967,"CAMK2A",1
"R-HSA-1839117","R-HSA-1839117","Signaling by cytosolic FGFR1 fusion mutants","1/45","12/2914",0.170651018783611,0.270197446407385,0.145327804738967,"STAT3",1
"R-HSA-202427","R-HSA-202427","Phosphorylation of CD3 and TCR zeta chains","1/45","12/2914",0.170651018783611,0.270197446407385,0.145327804738967,"LCK",1
"R-HSA-2691230","R-HSA-2691230","Signaling by NOTCH1 HD Domain Mutants in Cancer","1/45","12/2914",0.170651018783611,0.270197446407385,0.145327804738967,"NOTCH1",1
"R-HSA-2691232","R-HSA-2691232","Constitutive Signaling by NOTCH1 HD Domain Mutants","1/45","12/2914",0.170651018783611,0.270197446407385,0.145327804738967,"NOTCH1",1
"R-HSA-381070","R-HSA-381070","IRE1alpha activates chaperones","1/45","12/2914",0.170651018783611,0.270197446407385,0.145327804738967,"GSK3A",1
"R-HSA-381771","R-HSA-381771","Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)","1/45","12/2914",0.170651018783611,0.270197446407385,0.145327804738967,"PAX6",1
"R-HSA-389359","R-HSA-389359","CD28 dependent Vav1 pathway","1/45","12/2914",0.170651018783611,0.270197446407385,0.145327804738967,"LCK",1
"R-HSA-389948","R-HSA-389948","PD-1 signaling","1/45","12/2914",0.170651018783611,0.270197446407385,0.145327804738967,"LCK",1
"R-HSA-9020558","R-HSA-9020558","Interleukin-2 signaling","1/45","12/2914",0.170651018783611,0.270197446407385,0.145327804738967,"LCK",1
"R-HSA-1368082","R-HSA-1368082","RORA activates gene expression","1/45","13/2914",0.183511357913431,0.281817600024769,0.151577795027173,"EP300",1
"R-HSA-190322","R-HSA-190322","FGFR4 ligand binding and activation","1/45","13/2914",0.183511357913431,0.281817600024769,0.151577795027173,"FGF19",1
"R-HSA-3906995","R-HSA-3906995","Diseases associated with O-glycosylation of proteins","1/45","13/2914",0.183511357913431,0.281817600024769,0.151577795027173,"NOTCH1",1
"R-HSA-5689901","R-HSA-5689901","Metalloprotease DUBs","1/45","13/2914",0.183511357913431,0.281817600024769,0.151577795027173,"EP300",1
"R-HSA-6807505","R-HSA-6807505","RNA polymerase II transcribes snRNA genes","1/45","13/2914",0.183511357913431,0.281817600024769,0.151577795027173,"SP1",1
"R-HSA-9614657","R-HSA-9614657","FOXO-mediated transcription of cell death genes","1/45","13/2914",0.183511357913431,0.281817600024769,0.151577795027173,"EP300",1
"R-HSA-2644602","R-HSA-2644602","Signaling by NOTCH1 PEST Domain Mutants in Cancer","2/45","51/2914",0.185406315805769,0.281817600024769,0.151577795027173,"NOTCH1/EP300",2
"R-HSA-2644603","R-HSA-2644603","Signaling by NOTCH1 in Cancer","2/45","51/2914",0.185406315805769,0.281817600024769,0.151577795027173,"NOTCH1/EP300",2
"R-HSA-2644606","R-HSA-2644606","Constitutive Signaling by NOTCH1 PEST Domain Mutants","2/45","51/2914",0.185406315805769,0.281817600024769,0.151577795027173,"NOTCH1/EP300",2
"R-HSA-2894858","R-HSA-2894858","Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer","2/45","51/2914",0.185406315805769,0.281817600024769,0.151577795027173,"NOTCH1/EP300",2
"R-HSA-2894862","R-HSA-2894862","Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants","2/45","51/2914",0.185406315805769,0.281817600024769,0.151577795027173,"NOTCH1/EP300",2
"R-HSA-8951664","R-HSA-8951664","Neddylation","2/45","51/2914",0.185406315805769,0.281817600024769,0.151577795027173,"HIF1A/SOCS3",2
"R-HSA-2426168","R-HSA-2426168","Activation of gene expression by SREBF (SREBP)","1/45","14/2914",0.196176641916843,0.288360231536619,0.155096800434054,"SP1",1
"R-HSA-400508","R-HSA-400508","Incretin synthesis, secretion, and inactivation","1/45","14/2914",0.196176641916843,0.288360231536619,0.155096800434054,"PAX6",1
"R-HSA-5654228","R-HSA-5654228","Phospholipase C-mediated cascade; FGFR4","1/45","14/2914",0.196176641916843,0.288360231536619,0.155096800434054,"FGF19",1
"R-HSA-68867","R-HSA-68867","Assembly of the pre-replicative complex","1/45","14/2914",0.196176641916843,0.288360231536619,0.155096800434054,"E2F1",1
"R-HSA-877312","R-HSA-877312","Regulation of IFNG signaling","1/45","14/2914",0.196176641916843,0.288360231536619,0.155096800434054,"SOCS3",1
"R-HSA-8983432","R-HSA-8983432","Interleukin-15 signaling","1/45","14/2914",0.196176641916843,0.288360231536619,0.155096800434054,"STAT3",1
"R-HSA-918233","R-HSA-918233","TRAF3-dependent IRF activation pathway","1/45","14/2914",0.196176641916843,0.288360231536619,0.155096800434054,"EP300",1
"R-HSA-927802","R-HSA-927802","Nonsense-Mediated Decay (NMD)","1/45","14/2914",0.196176641916843,0.288360231536619,0.155096800434054,"PPP2CA",1
"R-HSA-9620244","R-HSA-9620244","Long-term potentiation","1/45","14/2914",0.196176641916843,0.288360231536619,0.155096800434054,"CAMK2A",1
"R-HSA-975957","R-HSA-975957","Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)","1/45","14/2914",0.196176641916843,0.288360231536619,0.155096800434054,"PPP2CA",1
"R-HSA-1632852","R-HSA-1632852","Macroautophagy","2/45","53/2914",0.196666736859405,0.288360231536619,0.155096800434054,"CSNK2A1/CSNK2A2",2
"R-HSA-1433559","R-HSA-1433559","Regulation of KIT signaling","1/45","15/2914",0.208649762990547,0.299301071975451,0.160981416828901,"LCK",1
"R-HSA-3214842","R-HSA-3214842","HDMs demethylate histones","1/45","15/2914",0.208649762990547,0.299301071975451,0.160981416828901,"KDM6A",1
"R-HSA-442982","R-HSA-442982","Ras activation upon Ca2+ influx through NMDA receptor","1/45","15/2914",0.208649762990547,0.299301071975451,0.160981416828901,"CAMK2A",1
"R-HSA-6803204","R-HSA-6803204","TP53 Regulates Transcription of Genes Involved in Cytochrome C Release","1/45","15/2914",0.208649762990547,0.299301071975451,0.160981416828901,"TP53",1
"R-HSA-69541","R-HSA-69541","Stabilization of p53","1/45","15/2914",0.208649762990547,0.299301071975451,0.160981416828901,"TP53",1
"R-HSA-9617324","R-HSA-9617324","Negative regulation of NMDA receptor-mediated neuronal transmission","1/45","15/2914",0.208649762990547,0.299301071975451,0.160981416828901,"CAMK2A",1
"R-HSA-76002","R-HSA-76002","Platelet activation, signaling and aggregation","4/45","153/2914",0.20872311598288,0.299301071975451,0.160981416828901,"MAPK3/LCK/MAPK1/PRKCD",4
"R-HSA-3232118","R-HSA-3232118","SUMOylation of transcription factors","1/45","16/2914",0.22093357142981,0.312874871341595,0.168282190726204,"TP53",1
"R-HSA-5627123","R-HSA-5627123","RHO GTPases activate PAKs","1/45","16/2914",0.22093357142981,0.312874871341595,0.168282190726204,"PPP1CB",1
"R-HSA-8852276","R-HSA-8852276","The role of GTSE1 in G2/M progression after G2 checkpoint","1/45","16/2914",0.22093357142981,0.312874871341595,0.168282190726204,"TP53",1
"R-HSA-8941858","R-HSA-8941858","Regulation of RUNX3 expression and activity","1/45","16/2914",0.22093357142981,0.312874871341595,0.168282190726204,"EP300",1
"R-HSA-388396","R-HSA-388396","GPCR downstream signalling","9/45","436/2914",0.221815578712878,0.31315140524171,0.168430926642009,"MAPK3/PPP2CA/MAPK1/RPS6KA2/RPS6KA3/PPP2CB/PRKCD/PPP2R1B/CAMK2A",9
"R-HSA-164952","R-HSA-164952","The role of Nef in HIV-1 replication and disease pathogenesis","1/45","17/2914",0.233030876221273,0.324960487941591,0.174782533911336,"LCK",1
"R-HSA-2029485","R-HSA-2029485","Role of phospholipids in phagocytosis","1/45","17/2914",0.233030876221273,0.324960487941591,0.174782533911336,"PRKCD",1
"R-HSA-399719","R-HSA-399719","Trafficking of AMPA receptors","1/45","17/2914",0.233030876221273,0.324960487941591,0.174782533911336,"CAMK2A",1
"R-HSA-399721","R-HSA-399721","Glutamate binding, activation of AMPA receptors and synaptic plasticity","1/45","17/2914",0.233030876221273,0.324960487941591,0.174782533911336,"CAMK2A",1
"R-HSA-8953854","R-HSA-8953854","Metabolism of RNA","3/45","109/2914",0.235976203566898,0.328064478129589,0.176452039252526,"PPP2CA/PRKCD/SET",3
"R-HSA-9612973","R-HSA-9612973","Autophagy","2/45","61/2914",0.242440610067185,0.33602710696242,0.180734801297885,"CSNK2A1/CSNK2A2",2
"R-HSA-1234176","R-HSA-1234176","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","1/45","18/2914",0.24494444562757,0.336429720500518,0.180951350130703,"HIF1A",1
"R-HSA-202433","R-HSA-202433","Generation of second messenger molecules","1/45","18/2914",0.24494444562757,0.336429720500518,0.180951350130703,"LCK",1
"R-HSA-5610783","R-HSA-5610783","Degradation of GLI2 by the proteasome","1/45","18/2914",0.24494444562757,0.336429720500518,0.180951350130703,"GSK3B",1
"R-HSA-983231","R-HSA-983231","Factors involved in megakaryocyte development and platelet production","2/45","62/2914",0.248214972826681,0.339897980807707,0.182816780997682,"GATA3/TP53",2
"R-HSA-9009391","R-HSA-9009391","Extra-nuclear estrogen signaling","2/45","63/2914",0.253995509174302,0.342236010351842,0.184074308430238,"MAPK3/MAPK1",2
"R-HSA-597592","R-HSA-597592","Post-translational protein modification","8/45","393/2914",0.254367682395337,0.342236010351842,0.184074308430238,"SMAD3/SMAD4/GATA3/EP300/HIF1A/SOCS3/TP53/PEX14",8
"R-HSA-5218921","R-HSA-5218921","VEGFR2 mediated cell proliferation","1/45","19/2914",0.256677007763882,0.342236010351842,0.184074308430238,"PRKCD",1
"R-HSA-5610785","R-HSA-5610785","GLI3 is processed to GLI3R by the proteasome","1/45","19/2914",0.256677007763882,0.342236010351842,0.184074308430238,"GSK3B",1
"R-HSA-5621575","R-HSA-5621575","CD209 (DC-SIGN) signaling","1/45","19/2914",0.256677007763882,0.342236010351842,0.184074308430238,"EP300",1
"R-HSA-5654719","R-HSA-5654719","SHC-mediated cascade:FGFR4","1/45","19/2914",0.256677007763882,0.342236010351842,0.184074308430238,"FGF19",1
"R-HSA-5654720","R-HSA-5654720","PI-3K cascade:FGFR4","1/45","19/2914",0.256677007763882,0.342236010351842,0.184074308430238,"FGF19",1
"R-HSA-9029569","R-HSA-9029569","NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux","1/45","19/2914",0.256677007763882,0.342236010351842,0.184074308430238,"EP300",1
"R-HSA-9609507","R-HSA-9609507","Protein localization","1/45","19/2914",0.256677007763882,0.342236010351842,0.184074308430238,"PEX14",1
"R-HSA-1655829","R-HSA-1655829","Regulation of cholesterol biosynthesis by SREBP (SREBF)","1/45","20/2914",0.268231251166516,0.351475432563021,0.189043803756195,"SP1",1
"R-HSA-450321","R-HSA-450321","JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1","1/45","20/2914",0.268231251166516,0.351475432563021,0.189043803756195,"MAPK9",1
"R-HSA-5578775","R-HSA-5578775","Ion homeostasis","1/45","20/2914",0.268231251166516,0.351475432563021,0.189043803756195,"CAMK2A",1
"R-HSA-73854","R-HSA-73854","RNA Polymerase I Promoter Clearance","1/45","20/2914",0.268231251166516,0.351475432563021,0.189043803756195,"MAPK3",1
"R-HSA-73864","R-HSA-73864","RNA Polymerase I Transcription","1/45","20/2914",0.268231251166516,0.351475432563021,0.189043803756195,"MAPK3",1
"R-HSA-8936459","R-HSA-8936459","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","1/45","20/2914",0.268231251166516,0.351475432563021,0.189043803756195,"EP300",1
"R-HSA-111465","R-HSA-111465","Apoptotic cleavage of cellular proteins","1/45","21/2914",0.279609825353629,0.362221819208111,0.194823831660872,"PRKCD",1
"R-HSA-3781865","R-HSA-3781865","Diseases of glycosylation","1/45","21/2914",0.279609825353629,0.362221819208111,0.194823831660872,"NOTCH1",1
"R-HSA-389357","R-HSA-389357","CD28 dependent PI3K/Akt signaling","1/45","21/2914",0.279609825353629,0.362221819208111,0.194823831660872,"LCK",1
"R-HSA-5654712","R-HSA-5654712","FRS-mediated FGFR4 signaling","1/45","21/2914",0.279609825353629,0.362221819208111,0.194823831660872,"FGF19",1
"R-HSA-1250196","R-HSA-1250196","SHC1 events in ERBB2 signaling","1/45","22/2914",0.290815341378202,0.368366099079055,0.198128580529593,"PRKCD",1
"R-HSA-1266695","R-HSA-1266695","Interleukin-7 signaling","1/45","22/2914",0.290815341378202,0.368366099079055,0.198128580529593,"STAT3",1
"R-HSA-201722","R-HSA-201722","Formation of the beta-catenin:TCF transactivating complex","1/45","22/2914",0.290815341378202,0.368366099079055,0.198128580529593,"EP300",1
"R-HSA-69563","R-HSA-69563","p53-Dependent G1 DNA Damage Response","1/45","22/2914",0.290815341378202,0.368366099079055,0.198128580529593,"TP53",1
"R-HSA-69580","R-HSA-69580","p53-Dependent G1/S DNA damage checkpoint","1/45","22/2914",0.290815341378202,0.368366099079055,0.198128580529593,"TP53",1
"R-HSA-8866654","R-HSA-8866654","E3 ubiquitin ligases ubiquitinate target proteins","1/45","22/2914",0.290815341378202,0.368366099079055,0.198128580529593,"PEX14",1
"R-HSA-9022692","R-HSA-9022692","Regulation of MECP2 expression and activity","1/45","22/2914",0.290815341378202,0.368366099079055,0.198128580529593,"CAMK2A",1
"R-HSA-9024446","R-HSA-9024446","NR1H2 and NR1H3-mediated signaling","1/45","22/2914",0.290815341378202,0.368366099079055,0.198128580529593,"EP300",1
"R-HSA-201451","R-HSA-201451","Signaling by BMP","1/45","23/2914",0.301850372373354,0.380231408293507,0.204510429668483,"SMAD4",1
"R-HSA-69002","R-HSA-69002","DNA Replication Pre-Initiation","1/45","23/2914",0.301850372373354,0.380231408293507,0.204510429668483,"E2F1",1
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","3/45","125/2914",0.303765083469327,0.381589195763122,0.205240726253018,"MAPK1/PTPRB/PRKCD",3
"R-HSA-2219530","R-HSA-2219530","Constitutive Signaling by Aberrant PI3K in Cancer","2/45","72/2914",0.306059725758479,0.382303375509649,0.205624853402004,"LCK/FGF19",2
"R-HSA-5621481","R-HSA-5621481","C-type lectin receptors (CLRs)","2/45","72/2914",0.306059725758479,0.382303375509649,0.205624853402004,"EP300/PRKCD",2
"R-HSA-1839124","R-HSA-1839124","FGFR1 mutant receptor activation","1/45","24/2914",0.31271745409013,0.382303375509649,0.205624853402004,"STAT3",1
"R-HSA-2172127","R-HSA-2172127","DAP12 interactions","1/45","24/2914",0.31271745409013,0.382303375509649,0.205624853402004,"LCK",1
"R-HSA-2424491","R-HSA-2424491","DAP12 signaling","1/45","24/2914",0.31271745409013,0.382303375509649,0.205624853402004,"LCK",1
"R-HSA-2559586","R-HSA-2559586","DNA Damage/Telomere Stress Induced Senescence","1/45","24/2914",0.31271745409013,0.382303375509649,0.205624853402004,"TP53",1
"R-HSA-5625740","R-HSA-5625740","RHO GTPases activate PKNs","1/45","24/2914",0.31271745409013,0.382303375509649,0.205624853402004,"PPP1CB",1
"R-HSA-69615","R-HSA-69615","G1/S DNA Damage Checkpoints","1/45","24/2914",0.31271745409013,0.382303375509649,0.205624853402004,"TP53",1
"R-HSA-8854691","R-HSA-8854691","Interleukin-20 family signaling","1/45","24/2914",0.31271745409013,0.382303375509649,0.205624853402004,"STAT3",1
"R-HSA-912694","R-HSA-912694","Regulation of IFNA signaling","1/45","24/2914",0.31271745409013,0.382303375509649,0.205624853402004,"SOCS3",1
"R-HSA-8864260","R-HSA-8864260","Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","1/45","25/2914",0.323419085427827,0.394329152286334,0.212093011271274,"EP300",1
"R-HSA-372790","R-HSA-372790","Signaling by GPCR","9/45","486/2914",0.33106974137973,0.40180666069759,0.216114847512785,"MAPK3/PPP2CA/MAPK1/RPS6KA2/RPS6KA3/PPP2CB/PRKCD/PPP2R1B/CAMK2A",9
"R-HSA-350054","R-HSA-350054","Notch-HLH transcription pathway","1/45","26/2914",0.333957728956988,0.40180666069759,0.216114847512785,"NOTCH1",1
"R-HSA-5654716","R-HSA-5654716","Downstream signaling of activated FGFR4","1/45","26/2914",0.333957728956988,0.40180666069759,0.216114847512785,"FGF19",1
"R-HSA-75153","R-HSA-75153","Apoptotic execution phase","1/45","26/2914",0.333957728956988,0.40180666069759,0.216114847512785,"PRKCD",1
"R-HSA-8939902","R-HSA-8939902","Regulation of RUNX2 expression and activity","1/45","26/2914",0.333957728956988,0.40180666069759,0.216114847512785,"GSK3B",1
"R-HSA-2122948","R-HSA-2122948","Activated NOTCH1 Transmits Signal to the Nucleus","1/45","27/2914",0.344335811435152,0.409966396904515,0.220503625297211,"NOTCH1",1
"R-HSA-5689896","R-HSA-5689896","Ovarian tumor domain proteases","1/45","27/2914",0.344335811435152,0.409966396904515,0.220503625297211,"TP53",1
"R-HSA-8852135","R-HSA-8852135","Protein ubiquitination","1/45","27/2914",0.344335811435152,0.409966396904515,0.220503625297211,"PEX14",1
"R-HSA-8939236","R-HSA-8939236","RUNX1 regulates transcription of genes involved in differentiation of HSCs","1/45","27/2914",0.344335811435152,0.409966396904515,0.220503625297211,"GATA3",1
"R-HSA-114604","R-HSA-114604","GPVI-mediated activation cascade","1/45","28/2914",0.354555724315449,0.417771086015102,0.224701438230653,"LCK",1
"R-HSA-6781823","R-HSA-6781823","Formation of TC-NER Pre-Incision Complex","1/45","28/2914",0.354555724315449,0.417771086015102,0.224701438230653,"EP300",1
"R-HSA-8957322","R-HSA-8957322","Metabolism of steroids","1/45","28/2914",0.354555724315449,0.417771086015102,0.224701438230653,"SP1",1
"R-HSA-933541","R-HSA-933541","TRAF6 mediated IRF7 activation","1/45","28/2914",0.354555724315449,0.417771086015102,0.224701438230653,"EP300",1
"R-HSA-446652","R-HSA-446652","Interleukin-1 family signaling","2/45","82/2914",0.363207539668918,0.42414959147235,0.228132167158489,"SMAD3/STAT3",2
"R-HSA-186763","R-HSA-186763","Downstream signal transduction","1/45","29/2914",0.36461982424816,0.42414959147235,0.228132167158489,"STAT3",1
"R-HSA-1980145","R-HSA-1980145","Signaling by NOTCH2","1/45","29/2914",0.36461982424816,0.42414959147235,0.228132167158489,"EP300",1
"R-HSA-381119","R-HSA-381119","Unfolded Protein Response (UPR)","1/45","29/2914",0.36461982424816,0.42414959147235,0.228132167158489,"GSK3A",1
"R-HSA-418597","R-HSA-418597","G alpha (z) signalling events","1/45","29/2914",0.36461982424816,0.42414959147235,0.228132167158489,"PRKCD",1
"R-HSA-5633008","R-HSA-5633008","TP53 Regulates Transcription of Cell Death Genes","1/45","30/2914",0.374530433575312,0.434569663385095,0.233736684138336,"TP53",1
"R-HSA-389356","R-HSA-389356","CD28 co-stimulation","1/45","31/2914",0.384289840818415,0.443635866868854,0.238613012420229,"LCK",1
"R-HSA-5655302","R-HSA-5655302","Signaling by FGFR1 in disease","1/45","31/2914",0.384289840818415,0.443635866868854,0.238613012420229,"STAT3",1
"R-HSA-447115","R-HSA-447115","Interleukin-12 family signaling","1/45","32/2914",0.393900301159439,0.452439640626459,0.243348190826327,"STAT3",1
"R-HSA-6782135","R-HSA-6782135","Dual incision in TC-NER","1/45","32/2914",0.393900301159439,0.452439640626459,0.243348190826327,"EP300",1
"R-HSA-6782210","R-HSA-6782210","Gap-filling DNA repair synthesis and ligation in TC-NER","1/45","33/2914",0.403364036915104,0.462145730736903,0.248568687123034,"EP300",1
"R-HSA-1169408","R-HSA-1169408","ISG15 antiviral mechanism","1/45","34/2914",0.412683238004594,0.46695671595557,0.251156313060129,"MAPK3",1
"R-HSA-1834949","R-HSA-1834949","Cytosolic sensors of pathogen-associated DNA ","1/45","34/2914",0.412683238004594,0.46695671595557,0.251156313060129,"EP300",1
"R-HSA-3214847","R-HSA-3214847","HATs acetylate histones","1/45","34/2914",0.412683238004594,0.46695671595557,0.251156313060129,"EP300",1
"R-HSA-5693565","R-HSA-5693565","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks","1/45","34/2914",0.412683238004594,0.46695671595557,0.251156313060129,"TP53",1
"R-HSA-6796648","R-HSA-6796648","TP53 Regulates Transcription of DNA Repair Genes","1/45","34/2914",0.412683238004594,0.46695671595557,0.251156313060129,"TP53",1
"R-HSA-1169410","R-HSA-1169410","Antiviral mechanism by IFN-stimulated genes","1/45","35/2914",0.421860062410772,0.47149065798851,0.253594929158178,"MAPK3",1
"R-HSA-5576891","R-HSA-5576891","Cardiac conduction","1/45","35/2914",0.421860062410772,0.47149065798851,0.253594929158178,"CAMK2A",1
"R-HSA-5610787","R-HSA-5610787","Hedgehog 'off' state","1/45","35/2914",0.421860062410772,0.47149065798851,0.253594929158178,"GSK3B",1
"R-HSA-5628897","R-HSA-5628897","TP53 Regulates Metabolic Genes","1/45","35/2914",0.421860062410772,0.47149065798851,0.253594929158178,"TP53",1
"R-HSA-5693606","R-HSA-5693606","DNA Double Strand Break Response","1/45","35/2914",0.421860062410772,0.47149065798851,0.253594929158178,"TP53",1
"R-HSA-2565942","R-HSA-2565942","Regulation of PLK1 Activity at G2/M Transition","1/45","37/2914",0.439795056145559,0.489137916103353,0.263086644626226,"PPP1CB",1
"R-HSA-3899300","R-HSA-3899300","SUMOylation of transcription cofactors","1/45","37/2914",0.439795056145559,0.489137916103353,0.263086644626226,"EP300",1
"R-HSA-373755","R-HSA-373755","Semaphorin interactions","1/45","38/2914",0.448557385820029,0.497669508355068,0.267675428085713,"GSK3B",1
"R-HSA-6781827","R-HSA-6781827","Transcription-Coupled Nucleotide Excision Repair (TC-NER)","1/45","39/2914",0.457185660381259,0.504786104440325,0.271503144816703,"EP300",1
"R-HSA-983712","R-HSA-983712","Ion channel transport","1/45","39/2914",0.457185660381259,0.504786104440325,0.271503144816703,"CAMK2A",1
"R-HSA-381340","R-HSA-381340","Transcriptional regulation of white adipocyte differentiation","1/45","40/2914",0.465681884827466,0.511689010798372,0.27521592686062,"EP300",1
"R-HSA-4086398","R-HSA-4086398","Ca2+ pathway","1/45","40/2914",0.465681884827466,0.511689010798372,0.27521592686062,"CAMK2A",1
"R-HSA-8986944","R-HSA-8986944","Transcriptional Regulation by MECP2","1/45","41/2914",0.474048034856263,0.519629576669365,0.279486822169811,"CAMK2A",1
"R-HSA-109704","R-HSA-109704","PI3K Cascade","1/45","42/2914",0.48228605728281,0.523624862192765,0.28163571766139,"FGF19",1
"R-HSA-2980736","R-HSA-2980736","Peptide hormone metabolism","1/45","42/2914",0.48228605728281,0.523624862192765,0.28163571766139,"PAX6",1
"R-HSA-6783783","R-HSA-6783783","Interleukin-10 signaling","1/45","42/2914",0.48228605728281,0.523624862192765,0.28163571766139,"STAT3",1
"R-HSA-909733","R-HSA-909733","Interferon alpha/beta signaling","1/45","42/2914",0.48228605728281,0.523624862192765,0.28163571766139,"SOCS3",1
"R-HSA-1280218","R-HSA-1280218","Adaptive Immune System","5/45","296/2914",0.487790381867629,0.528343026440947,0.284173419115283,"PPP2CA/LCK/SOCS3/PPP2CB/PPP2R1B",5
"R-HSA-202424","R-HSA-202424","Downstream TCR signaling","1/45","43/2914",0.490397870452125,0.529908599351111,0.285015474720242,"LCK",1
"R-HSA-3108232","R-HSA-3108232","SUMO E3 ligases SUMOylate target proteins","2/45","107/2914",0.497230096510355,0.535999354430244,0.288291434862065,"EP300/TP53",2
"R-HSA-1227986","R-HSA-1227986","Signaling by ERBB2","1/45","44/2914",0.498385364645665,0.535999354430244,0.288291434862065,"PRKCD",1
"R-HSA-1226099","R-HSA-1226099","Signaling by FGFR in disease","1/45","45/2914",0.506250402482231,0.540396701749117,0.290656582427388,"STAT3",1
"R-HSA-2990846","R-HSA-2990846","SUMOylation","2/45","109/2914",0.507214448132943,0.540396701749117,0.290656582427388,"EP300/TP53",2
"R-HSA-3247509","R-HSA-3247509","Chromatin modifying enzymes","2/45","109/2914",0.507214448132943,0.540396701749117,0.290656582427388,"EP300/KDM6A",2
"R-HSA-4839726","R-HSA-4839726","Chromatin organization","2/45","109/2914",0.507214448132943,0.540396701749117,0.290656582427388,"EP300/KDM6A",2
"R-HSA-112399","R-HSA-112399","IRS-mediated signalling","1/45","46/2914",0.513994819313287,0.54380890396023,0.292491862010003,"FGF19",1
"R-HSA-383280","R-HSA-383280","Nuclear Receptor transcription pathway","1/45","46/2914",0.513994819313287,0.54380890396023,0.292491862010003,"NR4A1",1
"R-HSA-69473","R-HSA-69473","G2/M DNA damage checkpoint","1/45","46/2914",0.513994819313287,0.54380890396023,0.292491862010003,"TP53",1
"R-HSA-162909","R-HSA-162909","Host Interactions of HIV factors","1/45","49/2914",0.536522296425889,0.565021171293777,0.303901045501962,"LCK",1
"R-HSA-186797","R-HSA-186797","Signaling by PDGF","1/45","49/2914",0.536522296425889,0.565021171293777,0.303901045501962,"STAT3",1
"R-HSA-2428928","R-HSA-2428928","IRS-related events triggered by IGF1R","1/45","50/2914",0.543802050932288,0.571368053514109,0.307314765625087,"FGF19",1
"R-HSA-2404192","R-HSA-2404192","Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)","1/45","51/2914",0.550969965634819,0.574925181531985,0.309227994683639,"FGF19",1
"R-HSA-2428924","R-HSA-2428924","IGF1R signaling cascade","1/45","51/2914",0.550969965634819,0.574925181531985,0.309227994683639,"FGF19",1
"R-HSA-69306","R-HSA-69306","DNA Replication","1/45","51/2914",0.550969965634819,0.574925181531985,0.309227994683639,"E2F1",1
"R-HSA-397014","R-HSA-397014","Muscle contraction","1/45","53/2914",0.564976969960197,0.586855349206947,0.315644728451567,"CAMK2A",1
"R-HSA-5607764","R-HSA-5607764","CLEC7A (Dectin-1) signaling","1/45","53/2914",0.564976969960197,0.586855349206947,0.315644728451567,"PRKCD",1
"R-HSA-5358351","R-HSA-5358351","Signaling by Hedgehog","1/45","55/2914",0.578556453676923,0.598235244618315,0.321765493989075,"GSK3B",1
"R-HSA-5696398","R-HSA-5696398","Nucleotide Excision Repair","1/45","55/2914",0.578556453676923,0.598235244618315,0.321765493989075,"EP300",1
"R-HSA-202403","R-HSA-202403","TCR signaling","1/45","59/2914",0.604483531200695,0.623630068388047,0.335424298094218,"LCK",1
"R-HSA-6806834","R-HSA-6806834","Signaling by MET","1/45","62/2914",0.622898828813384,0.639733932294826,0.344085886945278,"STAT3",1
"R-HSA-69481","R-HSA-69481","G2/M Checkpoints","1/45","62/2914",0.622898828813384,0.639733932294826,0.344085886945278,"TP53",1
"R-HSA-168928","R-HSA-168928","DDX58/IFIH1-mediated induction of interferon-alpha/beta","1/45","66/2914",0.646153594942828,0.662125930997594,0.356129598158909,"EP300",1
"R-HSA-202733","R-HSA-202733","Cell surface interactions at the vascular wall","1/45","69/2914",0.662668593292453,0.677526633500804,0.364412986162713,"LCK",1
"R-HSA-3858494","R-HSA-3858494","Beta-catenin independent WNT signaling","1/45","76/2914",0.69832765278133,0.712387941092364,0.383163412452726,"CAMK2A",1
"R-HSA-73894","R-HSA-73894","DNA Repair","2/45","157/2914",0.707629293699117,0.720265531086601,0.38740043569524,"EP300/TP53",2
"R-HSA-162906","R-HSA-162906","HIV Infection","1/45","80/2914",0.717020564974013,0.728199059305456,0.391667545748318,"LCK",1
"R-HSA-5693532","R-HSA-5693532","DNA Double-Strand Break Repair","1/45","81/2914",0.721513886983953,0.731134072143739,0.393246165303534,"TP53",1
"R-HSA-4420097","R-HSA-4420097","VEGFA-VEGFR2 Pathway","1/45","85/2914",0.738799824239796,0.746990509652654,0.401774673935984,"PRKCD",1
"R-HSA-983168","R-HSA-983168","Antigen processing: Ubiquitination & Proteasome degradation","1/45","88/2914",0.751071359824873,0.757718009026863,0.407544543174652,"SOCS3",1
"R-HSA-194138","R-HSA-194138","Signaling by VEGF","1/45","92/2914",0.766560008110065,0.771636564455164,0.415030746809911,"PRKCD",1
"R-HSA-983169","R-HSA-983169","Class I MHC mediated antigen processing & presentation","1/45","115/2914",0.838944729716783,0.842640521477649,0.453220779095781,"SOCS3",1
"R-HSA-382551","R-HSA-382551","Transport of small molecules","1/45","121/2914",0.853882213063807,0.855758877268343,0.460276589112474,"CAMK2A",1
"R-HSA-5663205","R-HSA-5663205","Infectious disease","1/45","126/2914",0.865287914763697,0.865287914763697,0.46540185627872,"LCK",1
